Graduate Theses, Dissertations, and Problem Reports
2015

Role of Stem-like Cells in Carbon Nanotube-Induced Pulmonary
Fibrosis
Amruta Manke

Follow this and additional works at: https://researchrepository.wvu.edu/etd

Recommended Citation
Manke, Amruta, "Role of Stem-like Cells in Carbon Nanotube-Induced Pulmonary Fibrosis" (2015).
Graduate Theses, Dissertations, and Problem Reports. 6156.
https://researchrepository.wvu.edu/etd/6156

This Dissertation is protected by copyright and/or related rights. It has been brought to you by the The Research
Repository @ WVU with permission from the rights-holder(s). You are free to use this Dissertation in any way that is
permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain
permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license
in the record and/ or on the work itself. This Dissertation has been accepted for inclusion in WVU Graduate Theses,
Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU.
For more information, please contact researchrepository@mail.wvu.edu.

Role of Stem-like Cells in Carbon Nanotube-Induced Pulmonary Fibrosis

Amruta Manke

Dissertation submitted
to the School of Pharmacy
at the West Virginia University
in partial fulfillment of the requirements for the degree of
Doctor of Philosophy
in
Pharmaceutical and Pharmacological Sciences

Yon Rojanasakul, Ph.D., Chair
Vincent Castranova, Ph.D.
Patrick Callery, Ph.D.
Liying Wang, Ph.D.
Grazyna Szklarz, Ph.D.

Department of Pharmaceutical & Pharmacological Sciences

Morgantown, West Virginia
2015
Keywords: Carbon Nanotube, Fibroblast Stem-like Cell, Lung Fibrosis, Collagen,
Oxidative Stress, Fiber Length, Surface Modification

Copyright 2015 Amruta Manke

[i]

ABSTRACT
Role of Stem-like Cells in Carbon Nanotube-Induced Pulmonary Fibrosis
Amruta Manke, B.Pharm, M.S.
Recent studies have shown that pulmonary exposure to (CNT) results in rapid and progressive
interstitial lung fibrosis in animals without causing persistent lung inflammation, which is
normally associated with other known fibrogenic agents. This unusual fibrogenic effect of CNT
raises important health issues since the exposure could result in deadly and incurable lung
fibrosis. Accumulating evidence indicates the fibrogenic potential of carbon nanotubes, however,
the underlying mechanism remains poorly addressed. Recent studies have demonstrated the
pathogenic role of mesenchymal stem cells in pulmonary fibrosis that differentiate into
myofibroblasts and contribute to disease progression. Understanding the molecular/cellular basis
of these fibrosis-associated stem cells during lung fibrosis is of critical importance. However, the
concept of stemness in the light of nanomaterial-induced fibrosis remains to be explored.
Fibroblast cells being the key players in fibrogenesis, we hypothesized that CNT exposure in
fibroblasts induce fibroblast stem-like cells (FSCs) which are critical for the CNT-induced
fibrogenic response. The long-term broad objective of this project was to develop an in vitro
model predictive of in vivo fibrogenic response and to devise preventive strategies for the
disease. The specific aims of this study included i) Determining the involvement of stemness
phenotype and underlying mechanism in CNT- induced lung fibrosis the and develop in vitro
screening assay which may be predictive of the in vivo fibrogenic response; ii) Investigate the
redox regulation of stem-like cells involved in CNT-driven fibrosis; iii) Evaluating the impact of
nanoparticle length and surface chemical modification influence stemness phenotype and the
resulting fibrogenic response. Our findings from Aim 1 indicated that indeed CNTs induced the
side population phenotype (indicative of the fibroblast stem-like cell phenotype) of primary lung
fibroblasts. The isolated FSCs displayed an elevated expression of fibrogenic and stem cell
markers indicating the reliability of the stem cell isolation method as well as supporting their role
in CNT-induced fibrogenesis. The study also developed and put forth an in vitro model of CNTinduced fibrotic nodule formation that correlates the development of stemness phenotype and
onset of fibrosis. Furthermore, the results from Aim 2 demonstrated that CNT-induced stemness
phenotype was under the redox regulation via identifying the key role of peroxides in CNTinduced FSC generation and collagen expression. Moreover, results from our second study
revealed that antioxidants abrogated the effect of CNT on stem-like cell generation suggesting
crucial role of redox in stemness generation and the fibrogenic effects. Our outcomes from the
Aim 3 demonstrated a length-dependent effect on stemness phenotype, with longer CNT
inducing higher FSCs compared to short CNTs as evidenced by side population and aldehyde
dehydrogenase assays. Pristine CNTs induced higher FSCs compared to modified CNTs;
however the effect was not statistically different. Long SWCNTs induced greater fibrogenic
response in vivo compared to short SWCNTs, supporting the potential utility of our in vitro FSC
[ii]

model to predict the fibrogenicity of CNTs. Such information will be important for development
and safer design and use of nanotechnology.
Findings from this work introduced the concept of fibroblast stem-like cells as a potential key
player in the pathogenesis of pulmonary fibrosis; which in turn may help in identifying novel
biomarkers and drug targets for early diagnosis and treatment of the disease. Furthermore, the in
vitro FSC model developed in this study may be utilized as a rapid screening tool for
fibrogenicity testing of not just carbon nanomaterials but also other nanoparticles and antifibrotic agents.
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PDGF, Platelet derived growth factor
WST, 1[2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium]
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FTIR, Fourier transform infrared spectroscopy
DEAB, Diethylaminobenzaldehyde
DPPC, Dipalmitoyl phosphatidylcholine

[viii]

TABLE OF CONTENTS
ABSTRACT.................................................................................................................................................. ii
DEDICATION ............................................................................................................................................. iv
ACKNOWLEDGEMENTS .......................................................................................................................... v
ABBREVIATIONS ..................................................................................................................................... vi
CHAPTER 1: PULMONARY TOXICITY AND FIBROGENIC RESPONSE OF CARBON
NANOTUBES .............................................................................................................................................. 2
Introduction ............................................................................................................................................... 2
Biological activities of CNT ..................................................................................................................... 5
Pulmonary toxicity of CNTs in vivo ......................................................................................................... 8
Figure I: Mechanisms of Lung Fibrosis .............................................................................................. 11
CNT-Induced Fibrosis ............................................................................................................................ 12
Specific Aims .......................................................................................................................................... 17
Table 1: Surface functionalization .......................................................................................................... 19
Table 2: Size and surface area................................................................................................................. 20
Table 3a: Presence of metal impurities ................................................................................................... 21
Table 3b: Dispersion status ..................................................................................................................... 22
References ............................................................................................................................................... 23
CHAPTER 2: ROLE OF FIBROBLAST STEM-LIKE CELLS IN CARBON NANOTUBE-INDUCED
LUNG FIBROSIS ....................................................................................................................................... 32
Abstract ................................................................................................................................................... 32
Introduction ............................................................................................................................................. 34
Figure S1: Role of stem-like cells in pulmonary fibrosis ................................................................... 37
Experimental Section .............................................................................................................................. 38
Figure S2: Working model for demonstrating CNT-induced fibroblast stem-like cell induction ...... 43
Results ..................................................................................................................................................... 44
Discussion ............................................................................................................................................... 49
Figure S3: Proposed mechanisms of CNT-induced lung fibrosis ....................................................... 52
References ............................................................................................................................................... 53
Figures .................................................................................................................................................... 57
Figure I: Carbon nanotubes (CNT) induce collagen production of human lung fibroblasts ............... 57
Figure II: CNT induce stem-like cells as indicated by side population (SP) phenotype..................... 59
Figure III: CNT-induced SP fibroblasts are a potential source of collagen I and α-SMA .................. 60

[ix]

Figure IV: Enhanced fibrogenic response of CNT-derived SP fibroblasts ......................................... 61
Figure V: CNT induce fibroblast nodule formation of human lung fibroblasts .................................. 62
Figure VI: CNT-induced SP is dose dependent .................................................................................. 63
Figure VII: CNT induced SP is cell type-dependent .......................................................................... 64
Figure VIII: CNT upregulate ALDH activity of lung fibroblasts ....................................................... 65
CHAPTER 3: ROLE OF REACTIVE OXYGEN SPECIES IN STEMNESS DEVELOPMENT AND
FIBROGENESIS INDUCED BY CARBON NANOTUBES .................................................................... 67
Abstract ................................................................................................................................................... 67
Introduction ............................................................................................................................................. 69
Experimental Section .............................................................................................................................. 72
Results ..................................................................................................................................................... 76
Discussion ............................................................................................................................................... 80
References ............................................................................................................................................... 85
Figures .................................................................................................................................................... 90
Figure I: Effect of SWCNT on ROS generation ................................................................................. 90
Figure II: Effect of SWCNT surface modification and length on ROS generation ............................ 91
Figure III: Effect of ROS on SWCNT-induced fibrogenic response .................................................. 92
Figure IV: Role of ROS in SWCNT-induced fibroblast stem-like cells ............................................. 93
Figure V: Antioxidant enzyme expression in SWCNT-induced fibroblast stem-like cells ................ 95
Table 1: Physicochemical characterization of SWCNTs .................................................................... 97
Table 2: Elemental analysis for short and long SWCNTs .................................................................. 97
CHAPTER 4: EFFECTS OF FIBER LENGTH AND SURFACE MODIFICATION ON CARBON
NANOTUBE-INDUCED FIBROBLAST STEM-LIKE CELLS AND LUNG FIBROSIS ...................... 99
Abstract ................................................................................................................................................... 99
Introduction ........................................................................................................................................... 100
Experimental Section ............................................................................................................................ 103
Results ................................................................................................................................................... 109
Discussion ............................................................................................................................................. 114
References ............................................................................................................................................. 118
Figures .................................................................................................................................................. 123
Table I: Physicochemical characterization of Single walled carbon nanotubes (SWCNTs) of different
surface modifications and lengths ..................................................................................................... 123
Table II: Elemental analysis for short and long SWCNTs ................................................................ 123

[x]

Figure I: FTIR spectra for pristine and surface modified Single walled carbon nanotubes (SWCNTs)
.......................................................................................................................................................... 124
Figure II: Effect of SWCNTs on cell viability .................................................................................. 125
Figure IV: Effect of SWCNT surface modification on FSC generation via Aldefluor® assay ......... 127
Figure V: Effect of SWCNT length on FSC induction determined by side population (SP) assay .. 128
Figure VI: Effect of SWCNT length on FSC generation via Aldeflour® assay ................................ 129
Figure VII: Effect of SWCNT length on fibrogenic response in vitro and in vivo........................... 130
Chapter 5: Executive Summary ................................................................................................................ 133
Introduction ........................................................................................................................................... 133
Specific Aim 1 ...................................................................................................................................... 135
Specific Aim 2 ...................................................................................................................................... 136
Specific Aim 3 ...................................................................................................................................... 137
Clinical & Translational Relevance ...................................................................................................... 138
References ............................................................................................................................................. 139

[xi]

CHAPTER 1
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CHAPTER 1: PULMONARY TOXICITY AND FIBROGENIC RESPONSE OF
CARBON NANOTUBES
Introduction
In recent years, a variety of nanomaterials have revolutionized the industrial field with
their rapidly emerging applications in the areas of biotechnology, electronics, medicinal drug
delivery, cosmetics, material science and aerospace engineering. Among the pool of recently
developed nanomaterials, carbon nanotubes (CNTs) have generated great interest commercially
with their unique physicochemical properties such as high tensile strength and conductivity [1,
2]. With abundant novel applications, the CNT market has been projected to expand substantially
within the next decade. However, such massive production is fraught with concerns for
environmental and occupational exposure. According to a National Science Foundation (NSF)
report, about 6 million workers will be involved with the nanotechnology industry by 2020
including 2 million within the United States, thus indicating a possible prevalence [3]. Human
exposures to manufactured nanomaterials are most likely to be observed in workers than the
general population [4]. A study reported exposure to polyacrylate paint containing nanoparticle
within a group of female workers. Affected workers clinically presented with pleural effusions,
progressive pulmonary fibrosis, pleural damage and death [4]. Moreover, a risk assessment study
on titanium dioxide nanomaterial observed occupational exposure within factory workers beyond
the acceptable limits during the packaging process [5]. However, nanomaterial exposure and
dosimetry data are insufficient for humans owing to the difficulty in detection and accurate
measurement tools for this unique and rapidly growing nanomaterial industry. The extraordinary
properties of CNTs need to compete with reports of CNT-associated toxicities, thus indicating
careful monitoring of human health and safety during their use [6]. Depending upon the type of
[2]

exposure, CNTs may penetrate the body through various routes such as the lungs and gut. CNTs
are high aspect ratio nanomaterials (HARNs) having at least one of their dimensions of the order
of 100 nm or less in size, as per the British Standards Institution (BSI) (2007). CNT structure
facilitates their entry, deposition and residence in the lungs and pleura, resulting in incomplete
phagocytosis and clearance from the lungs [7]. Owing to their bio-persistent and nonbiodegradable nature, and particularly the resemblance to needle-like asbestos fibers, CNTs are
believed to induce biologically harmful effects. CNTs are similar to asbestos in their fibrous
morphology, biopersistence, surface reactivity and the ability to translocate within the alveolar
regions and the deeper pleura of the lung [8]. Upon pulmonary exposure, CNTs generate an
acute inflammatory response, activate several cell signaling pathways [9, 10], and induce
genotoxicity [11, 12], mesothelioma [1, 8], diffuse interstitial fibrosis and granulomas similar to
that observed in asbestos-exposed animals and humans [13, 14]. However, they differ in their
chemical composition, surface charge and the ability to (i) enter mesothelial cells and (ii) induce
direct fibrogenic effects [8, 15, 16]. Lung toxicity appears to be the major consequence of CNT
exposure, ultimately contributing toward granuloma formation, epithelial hypertrophy and early
onset of fibrosis [17-20]. Accumulating evidence in the literature demonstrates the fibrogenic
potential of CNTs. Toxicity reports have indicated the ability of CNTs to translocate into the
surrounding areas of the lung causing systemic toxicity, granulomatous lesions, interstitial and
sub-pleural fibrosis [14, 22, 23]. However, the interactions of CNTs with the host at the
molecular and cellular levels remain largely unknown. Identification of molecular targets and
intracellular signaling is essential to the development of specific biomarkers for risk assessment
and early detection of CNT-induced pathogenesis. The pathologic effects of CNTs are likely to
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be influenced by their physicochemical properties, thus we will first describe the physical and
chemical properties of CNTs and their associated cellular toxicities.
Types and properties of CNTs
As per the British Standards Institute Report (2007), CNTs are HARNs having at least one of
their dimensions, i.e. the diameter less than 100 nm whereas the lengths vary from a wide range
of micrometers. CNTs are engineered nanomaterials made of graphene sheets that have been
rolled into seamless cylindrical structure. They are manufactured mainly via arc discharge,
chemical vapor deposition and laser ablation. All the three methods basically involve thermal
elimination of carbon atoms from carbon sources including graphite, or gaseous carbon-bearing
compounds such as CO, methane, ethylene or other hydrocarbons [24]. Post-synthesis, CNTs are
purified to eliminate residual organics such as soot or amorphous carbon and metals. They are
classified into two main types known as single walled carbon nanotubes (SWCNTs) and multiwalled carbon nanotubes (MWCNTs), both demonstrating outstanding chemical and thermal
stability. MWCNTs comprise of several single-walled tubes layered onto each other. SWCNTs
can be viewed as a single thick-graphite layer rolled into a cylindrical tube [25]. The nanoscale
and large surface area of CNTs allow them to interact efficiently with cells, albeit in an
undefined manner. Whether CNTs are inherently toxic or is it a wide array of external factors
such as length, surface modification, degree of dispersion and the presence of metal impurities
playing a role in CNT-induced toxicity is still a subject of intense investigations. Current
literature reveals that CNTs based on their type, fiber length, dispersion status and functionality
exert considerable variations in toxicities.

[4]

Evidence for adverse pulmonary outcomes following CNT exposure
Currently, there are no published reports of the adverse health effects in workers handling CNTs.
However, given the likelihood of developing robust pulmonary responses after inhalation of
particles and fibers, it is rational to assume that at an equivalent lung burden to CNTs, workers
may also be susceptible to developing these adverse lung effects. Nevertheless, mounting
evidence from animal studies raises serious health concerns for occupational hazards associated
with CNT exposure. Due to the lack of safety guidelines and suitable biomarkers for CNT
workplace exposure, occupational risk estimates are extrapolated from existing rodent models [7,
28].
Biological activities of CNT
Oxidative stress
One of the most frequently reported toxicity endpoints is the formation of ROS, which can be
either protective or harmful during biological interactions. Oxidative stress is an imbalance
between the production of ROS and their elimination by the host’s defense systems. Oxidative
stress amounts to DNA damage, lipid peroxidation and activation of signaling networks
associated with loss of cell growth, fibrosis and carcinogenesis [29, 30]. Following the exposure
to CNTs, ROS are induced intrinsically within the cell, extrinsically or indirectly via the effect of
internalized CNTs on mitochondrial respiration. The critical factors driving CNT-induced ROS
generation include active redox cycling on the surface of nanoparticles (NPs), oxidative
functional groups on the NPs and NP-cell interactions, especially in the lungs where there is a
rich pool of ROS producers like neutrophils and macrophages [29]. CNT-induced oxidative
stress is mainly followed by inflammation, cell injury, apoptosis and activation of cellular
signaling pathways such as mitogen-activated protein kinase (MAPK) and nuclear factor (NF)[5]

κB, which are implicated in the pathogenesis of lung fibrosis [31, 32]. Several studies have
demonstrated the role of CNTs in oxidative stress, one of the mechanisms being mitochondrial
damage [9].MWCNT exposure induces ROS production in a variety of cell lines as well as in
vivo [9, 33, 34]. Likewise, studies have demonstrated SWCNT-induced ROS generation in
multiple cell lines [10, 35, 36] and activation of intracellular signaling pathways including
MAPK, Akt, AP-1 and NF-κB in mesothelial cells in a dose-dependent manner [37]. These
findings indicate that CNT-induced oxidative stress may serve as an important intermediate
endpoint while assessing pulmonary toxicity of CNTs.
Genotoxicity
Since CNTs have been shown to possess asbestos-like pathogenicity, it is necessary to
characterize their genotoxic potential. Both MWCNT and SWCNT have been shown to exert
genotoxic effects in number of in vitro settings as evidenced by DNA strand breakage, DNA
base oxidation, chromosomal aberrations and gene mutations [38-42]. Intrinsic ROS production,
CNT-induced inflammation and oxidative stress are some of the proposed mechanisms for CNTdriven genotoxicity [43, 44]. More recent studies have revealed the potential toxicity associated
with chronic exposure of CNTs which results in a malignant and neoplastic phenotype and
tumorigenesis as well a novel feature of stem-like induction in human lung cells [45, 46].
Inflammation
Inflammation is commonly observed upon inhalation of CNTs. Characterization of the
inflammatory process upon CNT exposure is necessary since inflammation is associated with
other pathologic disorders such as fibrosis and cancer. Given the interplay between the
inflammatory response and ROS generation, both effects are closely linked and one leads to the
other [44]. Particle deposition in the lung causes recruitment of inflammatory cells that generate
[6]

ROS, clastogenic factors and cytokines, either harming or stimulating resident lung cells [32].
Oxidative stress produced from CNT exposure activates pro-inflammatory transcription factors
such as NF-κB, AP-1 and MAPK [37]. The inflammatory cytokines tumor necrosis factor
(TNF)-alpha and interleukin (IL)-1beta are well known mediators of fibrotic lung diseases by
activating the pro-fibrotic transforming growth factor (TGF)-b and platelet derived growth factor
(PDGF), respectively. Such stimulation leads to differentiation of fibroblasts to myofibroblasts
and their production of extracellular matrix (ECM) proteins [32, 47, 48]. Several reports indicate
that MWCNTs and SWCNTs induce a panel of pro-fibrotic inflammatory cytokines and
chemokines in human lung cells including TNF-a and IL-8 [49], IL-1b, IL-6, IL-10 and
monocyte chemoattractant protein (MCP)-1 [9], NLRP3 inflammasome (Paloma¨ki et al., 2011),
IL-13/33 [50] and inflammatory enzymes such as cyclooxygenase (COX)-2 and inducible nitric
oxide synthase (iNOS) [51].
Permeability barrier function
Alterations in respiratory barrier function is of particular importance to CNT-induced toxicity
since respiratory epithelial cells present a protective barrier against inhaled particles and
constitute a major determinant of the interaction of the particles with other body compartments.
Epithelial cells are responsible for the formation and maintenance of tight junction barrier, only
permitting polarized secretory functions and preventing access to xenobiotics and pathogens
[52]. Consequently, respiratory barrier function plays a pivotal role in CNT-related inhalation
hazards. MWCNTs have been shown to alter the paracellular permeability of airway epithelial
cells by interfering with the formation of tight junctions. The permeability altering effect of
CNTs was shown to be dependent on fiber length and functionalization [53, 54]. However, the
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underlying mechanisms of alteration and its effect on CNT-induced pathogenesis have not been
clearly elucidated.
Pulmonary toxicity of CNTs in vivo
Pulmonary function
CNTs can significantly hamper pulmonary function as demonstrated by an increase in expiratory
time [20], reduced bacterial clearance activity [22], and decreased lung compliance [55]. Both
SWCNT and MWCNT exacerbate ovalbumin-induced allergic airway inflammation in vivo [5658]. Collectively, these studies imply that individuals with pre-existing respiratory conditions
such as allergic asthma and bronchitis are more likely to be susceptible to CNT exposure [32].
Pleural disease
The structural similarity between asbestos and CNTs has raised a concern about the potential
damaging effect of CNTs on pleural mesothelium. Studies have demonstrated CNTs to reach the
pleural space [59], migrate from subpleural to intrapleural tissue [60], induce mesothelial cell
proliferation and mesothelioma formation [61, 62], and cause inflammation and pleural fibrosis
[13]. MWCNT injected into the peritoneal cavity of mice or rats generated fiber lengthdependent inflammation/genetic damage and mesothelioma [15]. These findings are important in
understanding whether CNTs have the potential to cause asbestos-like pleural lesions and
whether workers are at risk of developing mesothelioma after chronic CNT exposure.
Fibrosis
Over the past few years, there has been a considerable growth in the literature base documenting
dose and time-dependent biological effects of SWCNT and MWCNT exposure. Some early
reports provided evidence for intrinsic toxicity of CNTs and potential exposure to respirable
[8]

CNT particulate matters in workers [17, 20]. Pharyngeal aspiration of SWCNT in mice at the
dose of 10–40 µg/mouse induced acute inflammation, early onset of granulomas, alveolar wall
thickening, and progressive fibrosis [17]. Subsequent studies determined the influence of the
route of administration and dispersion status on the end toxic response. For instance, a short-term
SWCNT inhalation exposure was more effective than pharyngeal aspiration in causing lung
toxicity in mice as evidenced by a 4-fold greater inflammation and fibrosis than aspiration of the
same mass lung burden owing to aerosolized particle size during inhalation [20, 22]. Poorly
dispersed SWCNT in suspension was found to be restricted to the proximal alveolar regions
resulting in granulomatous lesions, whereas well-dispersed SWCNT deposited deeper into the
interstitial and pleural areas of the lung causing parenchymal granulomas and interstitial fibrosis
[63, 64]. Likewise, the biopersistence of MWCNT has been illustrated by a number of in
vivo studies suggesting similar spectrum of dose- and time-dependent pulmonary fibrogenic
responses [34, 39, 65]. Contrary to SWCNT, MWCNT was shown to induce a significant
increase in fibrosis after pulmonary aspiration compared to inhalation [13]. Acute pulmonary
exposure to inhaled MWCNT induced inflammation, fibrosis, and rare pleural penetration
indicating that MWCNT can reach the pleura after inhalation [66]. A recent long-term inhalation
study demonstrated that MWCNT induced a fibrotic response that persisted up to 336 days postexposure and exhibited particle size-dependent retention in the lungs [67]. Furthermore, inhaled
MWCNT were found to translocate to the parietal pleura, the respiratory musculature, liver,
kidney, heart and brain where they accumulate with time following exposure [68].
Despite similar qualitative fibrogenic responses, both MWCNT and SWCNT differ significantly
in how they are distributed within the lungs. SWCNT is more likely to interact with the lung
owing to its greater fiber count per mass than MWCNT [13]. Moreover, MWCNT is known to be
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recognized and phagocytosed by alveolar macrophages [34, 56], whereas SWCNT evades
macrophages which facilitates its entry into the alveolar interstitium [13]. However, both forms
of CNT induce damaging lung responses in vivo at doses physiologically relevant to potential
worker exposures. Pulmonary exposure to CNTs has illustrated systemic responses such as
increased inflammatory mediators in the blood, diminished ability of coronary arterioles to
respond to dilators, oxidative stress in aortic tissue and increased plaque formation in an
atherosclerotic mouse model [69-71]. Additional research is needed to understand the
mechanisms underlying these pulmonary and systemic responses to CNTs.
Besides the fibrogenic damage, long-term CNT exposure has been shown to promote malignant
transformation and induction of tumorigenesis, initiation of lung adenocarcinoma and tumor like
morphology in vivo at doses which approximate potential human occupational exposures [72,
73].

[10]

Figure I: Mechanisms of Lung Fibrosis
Irritants such as nano-particles induce epithelial injury resulting in infiltration of immune cells
such as neutrophils, eosinophils and alveolar macrophages at the site of tissue injury. Activated
neutrophils can exaggerate the ROS response. Moreover, ROS generation upon particle–cell
interactions activates cytokine growth receptor cascade. ROS-dependent activation of RTKs,
MAPK, Akt and NF-κB results in expression of genes related to inflammation and fibrosis. ROS
can also activate TGF-β to mediate the fibrogenic effects. Recruitment of leukocytes induces key
pro-fibrotic cytokines including TNF-a, IL-1β and IL-13, which can further damage the epithelial
cells. TNF-α and IL-1β stimulation upregulates TGF-b and PDGF, respectively, which in turn
increase collagen production via fibroblast and myofibroblast proliferation. Alternatively,
fibroblasts can directly induce fibrosis via proliferation and differentiation into myofibroblasts.
In addition, epithelial cells undergoing EMT expand the pool of fibroblasts and myofibroblasts
thereby driving fibrogenesis.
[11]

During the development of fibrosis, several common cellular events occur including epithelial
cell injury, infiltration of inflammatory cells, proliferation and transformation of fibroblasts into
myofibroblasts, and synthesis and deposition of ECM [9]. Unique to CNTs is their nonbiodegradable and biopersistent nature which likely prolongs the fibrotic process. Multiple
factors determine the severity and duration of CNT-induced fibrosis, which are discussed below
and are summarized in Figure 1.
CNT-Induced Fibrosis
Role of ROS
ROS is widely known to be involved in epithelial cell injury and fibrogenesis [74]. CNT
exposure results in ROS-dependent activation of several transcription factors and signaling
pathways including NF-κB, signal transducer and activator of transcription (STAT)-1, MAPK
and receptor tyrosine kinases (RTK), which are involved in the regulation of inflammation and
fibrosis [32]. CNT-induced ROS generation is likely to be a result of frustrated phagocytosis
which refers to the failure of the macrophage to entirely engulf the long fibers, thus resulting in
an inflammatory condition [1]. Additionally, specific properties of CNTs such as metal
contaminants including iron, cobalt, tungsten and vanadium as well as reactive groups on the
CNT surface that have been attributed to pulmonary fibrotic response may induce oxidative
stress [21, 31, 75, 76]. Some of the common metal contaminants associated with pulmonary
fibrosis include iron, cobalt, tungsten and vanadium.
Role of pre-existing inflammation
Little has been reported about the risk and possibility of a fibrogenic response following CNT
exposure in conditions with pre-existing inflammation. Studies have reported how bacterial-
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derived products modify CNT-related toxicities. In mice with prior bacterial infection,
pharyngeal aspiration of SWCNTs promotes inflammatory response, collagen synthesis, reduces
phagocytosis of bacteria by macrophages and bacterial clearance from the lungs, thereby
increasing host susceptibility to lung fibrosis [22]. Pre-exposure with lipopolysaccharide, an
endotoxin, exaggerates the fibrotic effects of CNTs by (i) intensifying acute inflammatory
response [77], (ii) increasing PDGF and its receptor resulting in fibroblast chemotaxis and
proliferation [78] and by (iii) elevating the expression of TNF-a and IL-1b resulting in collagen
synthesis and ECM deposition [22]. Together, these results support the role of pre-existing
inflammation in promoting CNT-induced lung fibrosis.
Role of inflammation
Numerous inflammatory and pro-fibrotic mediators such as TNF-a, IL-1b and TGF-b have been
implicated in the pathogenesis of fibrosis. Infiltration of immune cells such as eosinophils,
neutrophils and macrophages results in tissue injury and loss of epithelial integrity, thus
promoting tissue repair and fibrosis [79]. As mentioned earlier, CNT exposure initiates an
inflammatory cascade of cytokines in association with oxidative stress. There are reports
documenting inflammation induced fibrosis following CNT exposure. For example, MWCNTs
induce TNF-a resulting in fibrosis in vivo [19]. SWCNTs upon pharyngeal aspiration induce
robust inflammation and an early onset of fibrogenic response in vivo characterized by the
secretion of TNF-a, IL-1b and TGF-b as well as several biomarkers of oxidative stress. The
extent of fibrosis is dose and time dependent [20]. Inflammation-driven fibrosis causes
granuloma formation associated with epithelial hypertrophy, alveolar thickening and interstitial
fibrosis [19, 22]. Intratracheal instillation of SWCNTs results in early onset of lung fibrosis
driven by the secretion of a panel of inflammatory cytokines [14].
[13]

Role of angiogenesis
Angiogenesis is essential in the formation of new blood vessels, wound healing and tissue repair,
thus important in fibrogenesis. Vascular endothelial growth factor (VEGF) regulates the
angiogenic response by controlling the migration, proliferation and vasculature of endothelial
cells. Initial studies demonstrated neovascularization leading to anastomoses between the
systemic and pulmonary microvasculature of patients with pulmonary fibrosis [80]. VEGF and
TGF-b interact closely with respect to angiogenic and fibrogenic effects. A recent in vitro study
showed that SWCNT-induced fibroblast proliferation and collagen production is mediated by
VEGF and TGF-β1 [10]. This study also suggested a positive feedback loop between TGF-b and
VEGF during angiogenesis, which promotes the fibrotic process after SWCNT treatment.
Role of epithelial mesenchymal transition
Epithelial mesenchymal transition (EMT), a process characterized by the transition of fully
differentiated epithelial cells to a mesenchymal phenotype, has been suggested to play a key role
in fibrosis by serving as a cellular source of resident fibroblasts/myofibroblasts and by causing a
loss of epithelial barrier that acts as a defense during advanced stage fibrosis [81]. However,
whether or not EMT is a major source of these interstitial lung cells during fibrosis in vivo is still
unclear. EMT is brought about by various external stimuli including growth factors, cytokines
and hormones [82]. With regards to CNT-induced EMT, SWCNT exposure induced EMT of
lung epithelial cells which contributed significantly to fibroblast expansion [83]. A recent study
showed that the activation of the TGF-β/Smad2 signaling plays a critical role in the process of
the fibroblast-to-myofibroblast transition and the EMT induced by MWCNTs [84].
Physicochemical properties of CNTs affecting toxicities

[14]

Physicochemical factors alter the cytotoxicity of CNTs with respect to their cellular uptake,
internalization, phagocytosis and clearance from the body [26, 27]. For instance, even though the
functionalization of CNTs may aid their solubility and dispersion, it has been speculated to
facilitate their uptake and internalization into the systemic circulation. More detailed effects of
physicochemical properties of CNTs on their biological activities are provided below and are
summarized in Tables 1, 2 and 3.
Conclusions
The ability of CNTs to cause acute toxicities and chronic fibrotic effects depends on several
physicochemical factors such as particle dimension, dispersion status, functionalization and the
presence of transition metals. Understanding these factors will enable the design of safer CNT
products and their utilization. The cytotoxic and fibrogenic effects of CNTs appear to be
associated with their ability to induce oxidative stress and inflammatory and fibrogenic
cytokines. There is a close connection between oxidative stress and inflammatory response, as
well as cross-talk between inflammation and fibrosis as indicated by the multifunctional roles of
the induced cytokines, e.g. TGF-b, PDGF and MMPs. Interestingly, however, there have been
reports showing CNT-induced fibrosis with minimum inflammation and oxidative injury,
suggesting alternative pathways and mechanisms of fibrosis. Apart from the molecular and
cellular changes, other biological factors such as angiogenesis and EMT can also influence
fibrosis. EMT may contribute to the increased fibroblasts/myofibroblasts during CNT-induced
fibrosis through TGF-b, Smad and b-catenin signaling. Similarly, angiogenesis may promote
fibrosis through VEGF-mediated fibroblast proliferation and collagen synthesis.
Understanding Mechanism for CNT-Induced Pulmonary Fibrosis

[15]

Given the fibrogenic potential of CNT, major concern exists about the long-term human health
risks associated with chronic pulmonary CNT exposures. Several studies have demonstrated the
fibrogenic effects of CNTs given their ability to translocate into the surrounding areas in the lung
causing granulomatous lesions and interstitial and sub-pleural fibrosis. However, the
mechanisms underlying the disease process remain obscure due to the lack of understanding of
the cellular interactions and molecular targets involved. Since pulmonary fibrosis is
characterized via abnormal tissue repair, collagen production and excessive ECM accumulation,
identifying the cells that are the source of ECM production is fundamental to the understanding
of fibrosis mechanisms. Currently the paradigm of stem cells is being evaluated in dysfunctional
lung remodeling. Recent studies have demonstrated the pathogenic role of putative stem cells in
early stages of pulmonary fibrosis [85-87].
The role of stem cells in nanomaterial-induced pulmonary fibrosis is unknown. Since
fibroblasts are the key players in fibrogenesis, we hypothesize that CNT exposure in fibroblasts
induce fibroblast stem-like cells (FSCs) which are critical for the CNT-induced fibrogenic
response.
Our central hypothesis is that upon exposure to fibroblasts CNT are capable of inducing FSC
which are crucial for the fibroblast to myofibroblast transformation and the development of
fibrosis. We also hypothesize that oxidative stress induced by CNT is essential for the stemness
development.
The long term goal of this study was to develop an in vitro model which will be predictive of
the NM-induced fibrogenic response in vivo for a) detailed mechanistic study of stem-cell niche
in CNT-induced lung fibrogenesis, b) studying the role of oxidative stress in regulating fibrosis
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stem cells and their fibrogenic effects, and c) investigating the ability of different
physicochemical parameters of CNT to induce FSC.
Specific Aims
Aim 1: Characterize the role of fibroblast stem-like cells in CNT-induced lung fibrosis in vitro
1.1 Determine if CNT is capable of inducing FSC from normal lung fibroblasts.
1.2 Determine the functional role of FSC as a source of myofibroblasts and collagen production.
1.3 Evaluate the role of FSCs in fibrotic nodule formation in vitro.
Through this part of the study, we documented the evidence of FSC and their potential role in
CNT-induced fibrogenesis in in vitro settings. Additionally, we demonstrated the role of FSCs
in fibrogenesis through their upregulation of collagen and alpha-smooth muscle actin. The
developed in vitro model investigated whether stemness dictates the fibrogenic response induced
by CNT exposure.
Aim 2: Determine whether reactive oxygen species (ROS) production is critical for stemness
development in the event of CNT-induced fibrosis
2.1 Test whether ROS leads to stem cell phenotype in fibroblasts and identify which ROS are
important for the stemness development
2.2 Identify the antioxidant enzymes involved in the regulation of ROS required for inducing
stemness phenotype in fibroblasts.
The findings from this study reported the effect of oxidative stress on fibroblast stem-like cell
generation and fibrogenesis induced by CNT. Our study showed that, ROS, particularly the
peroxide species play a key role in SWCNT-induced stemness development and fibrogenic
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effects. Moreover, this study also documented the effect of fiber length and surface modification
on CNT-elicited oxidative stress.
Aim 3: Examine whether physicochemical characteristics of CNT govern the ability to induce
the stemness phenotype and thereby the resulting fibrogenic response
3.1 Test whether surface modifications of single-walled CNT (SWCNT) via different functional
groups {including carboxyl (COOH), nitrogen containing (NC), and hydroxyl (OH)} can alter
the stemness development.
3.2 Test whether the length of SWCNT is capable of driving the stem-like behavior as well as the
resulting fibrogenic response.
3.3 Develop a model which determines that the stemness phenotype is a predictive tool of the
fibrogenic response in vivo.
The results presented under this study revealed the role of physicochemical parameters of
SWCNT, particularly fiber length and surface modification in stemness development. Our data
indicated the potential usefulness of the in vitro stemness induction model as a predictive
screening tool for fibrogenicity testing of nanomaterials.

[18]

Studies related to surface functionalization, size and surface area, presence of metal impurities and dispersion status
Table 1: Surface functionalization
Type of CNT
SWCNT,
Control; and acid functionalized

System
LA4 mouse lung epithelial cells
and in vivo in CD1 mice

Effect
AF-SWCNT more cytotoxic than SWCNT in
vitro; exerted stronger inflammatory response
in vivo than control SWCNT

Study
[88]

MWCNT,
Functionalized; and nonfunctionalized

In vivo bone marrow cells of
Swiss-Webster mice

Functionalized MWCNT induced greater
clastogenic/genotoxic effects than nonfunctionalized MWCNT

[11]

SWCNT,
SWCNT-phenyl-SO3H;
SWCNT-phenyl-SO3Na; and
SWCNT-phenyl-(COOH)2

Human dermal fibroblasts

Cytotoxicity dependent on the degree of
sidewall functionalization

[89]

MWCNT,
Pristine; and carboxylated

In vivo mice

The degree of functionalization was inversely
proportional to hepatic toxicity

[90]

MWCNT,
Pristine; COOH-MWCNT; and NH2MWCNT
MWCNT,

A549 pneumocytes, in vivo

pulmonary toxicity, inflammatory response,
irrespective of nanotube functionalization

[91]

Chronic lung inflammation, fibrosis, and
collagen deposition: PEI-MWCNT induced the
strongest
effects, while NH2 and sw-NH2-MWCNT
exerted similar effects, and COOH and PEGMWCNT induced weaker effects than APMWCNT in vitro and in vivo

[92]

As-prepared (AP); COOH; PEG;
NH2; sw-NH2; and PEI-MWCNT

BEAS-2B and THP-1 cells, in
vivo

[19]

MWCNT; CNF; and carbon
nanoparticles

Human lung tumor cells

Functionalized carbon nanoparticles most toxic
compared to MWCNT and CNF

[93]

SWCNT,
Purified; and 6-amino-hexanoic acidderivatized (AHA-SWCNT)

Human epidermal keratinocytes

Functionalization induced mild cytotoxic
responses and maintained cell viability

[94]

Type of CNT
Purified MWCNT,
Short (220 nm); and long (825 nm)

System
Human acute monocytic
leukemia THP-1 cell line

Effect
Long CNT induced more inflammation

Study
[95]

SWCNT,
Long (0.5-100 μm); and short (0.5-2
μm)
MWCNT,
Long (5-9 μm); and short (0.5-2 μm)

Human epithelial Calu-3

Long MWCNT and SWCNT caused
significant disruption of barrier function

[53]

MWCNT,
Long (13 μm); and (56 μm);
tangled (1-5 μm); and (5-20 μm)

In vivo

Length-dependent inflammation and
granuloma formation

[60]

MWCNT,
Short (1-10 μm); long tangled (10-50
μm); long needle-like (>50 μm);
asbestos (4.6 μm); and carbon black

Primary human macrophages

Enhanced activation of NRLP3 inflammasome
and secretion of IL-1β, IL-1α by long
MWCNT

[96]

MWCNT,
Long; short; tangled;
Nickel nanowires (long and short)

In vivo

Length-dependent retention of CNTs
into lung pleura resulting in sustained
inflammation and progressive fibrosis

[97]

MWCNT,

Human peritoneal mesothelial

Thin MWCNT more inflammatory and

[15]

Table 2: Size and surface area

[20]

Dispersed thin (50 nm); aggregative
(2-20 nm); and thick (150 nm)

cells

carcinogenic

Purified MWCNT,
Thick (70 nm) and thin (9.4 nm)

Murine alveolar macrophages
and in vivo in rats

Thin MWCNT more toxic in vitro and in vivo

[98]

SWCNT (138 m2/g); carbon
nanofibers; CNF (21 m2/g); and
asbestos (8 m2/g)

In vivo C57BL/6 mice

SWCNT with high surface area induced more
oxidative stress, inflammation, lung damage
and fibrosis than CNF and asbestos

[64]

SWCNT; MWCNT; active carbon;
carbon black and carbon graphite

Human fibroblast cells

SWCNT with small surface area more toxic
than large particles

[99]

MWCNT; CNF; carbon nanoparticles

Human lung tumor cells

Size and aspect ratio-dependent cytotoxicity of
MWCNT

[93]

MWCNT,
short; and long

Murine macrophages

Short > long MWCNT in pro-inflammatory
cytokine secretion and oxidative stress

[100]

MWCNT; (NM400 and NM402) and
Crocidolite

Human fibroblast cells, in vivo
C57BL/6 mice

Long MWCNT induced more cell proliferation
in vitro and fibrosis in vivo

[101]

SWCNT,
Long SWCNT fibers (~13 μm);
Short SWCNT fibers (~ 1-2 μm)

Human lung fibroblasts, in vivo
C57BL/6 mice

Length-dependent ROS generation, TGF-β and
collagen I expression

[102]

Human keratinocytes

Loss of cell viability and oxidative stress were
due to the catalytic activity of SWCNT-

[76]

Table 3a: Presence of metal impurities

30wt% iron-rich SWCNT

[21]

associated iron content
MWCNT,
99% purity; 97% purity; and acidtreated 97% purity (surface oxidation
8%)

Human neuroblastoma cells

Loss of cell viability with reduction in CNT
purity

[103]

26wt% iron-rich SWCNT

Murine RAW 264.7
macrophages

Loss of intracellular thiols and lipid
hydroperoxide accumulation in macrophages

[104]

SWCNT,
(poor; and well dispersed)

In vivo C57BL/6 mice

Poorly dispersed SWCNT - proximal alveolar
regions resulting in granulomatous lesions;
well-dispersed CNT-alveolar interstitial and
pleural areas causing parenchymal granulomas
and interstitial fibrosis

[105]

SWCNT,
Survanta dispersed (SD-SWCNT);
and non-dispersed (ND-SWCNT)

Human lung epithelial BEAS2B cells

SD-SWCNT more fibrogenic than NDSWCNT both in vitro and in vivo

[79]

Table 3b: Dispersion status

[22]
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CHAPTER 2: ROLE OF FIBROBLAST STEM-LIKE CELLS IN CARBON
NANOTUBE-INDUCED LUNG FIBROSIS

Abstract
Among the pool of engineered nanomaterials, carbon nanotubes (CNTs) have generated great
interest commercially with their unique physicochemical properties and diverse applications;
however, the risk of their adverse health effects is not well understood. Recent studies have
shown that CNTs can induce pulmonary fibrosis, an incurable lung disease, but the underlying
mechanism is unclear. Since fibrosis is associated with aberrant tissue repair and extracellular
matrix (ECM) accumulation, identifying the cells that are responsible for the repair and ECM
production is fundamental to the understanding of fibrosis mechanism. We hypothesized that
CNTs induce fibroblast stem-like cells (FSCs) and that such induction is essential to the
development of fibrosis. Fluorescence activated cell sorting (FACS) was used to isolate FSCs
from CNT-treated normal human lung fibroblasts. The expression of stem cell markers and
fibrogenic markers was performed using Western blotting, immunofluorescence staining and
confocal microscopy. Our results demonstrated for the first time that CNTs can induce FSCs
from lung fibroblasts as evidenced by their side population (SP) property, aldehyde
dehydrogenase (ALDH) activity, and the expression of stem cell markers ABCG2 and
ALDH1A1. Furthermore, these cells, isolated from SP-positive FSCs, showed a high expression
of type I collagen and alpha-smooth muscle actin, which are key biomarkers of fibrosis, as
compared to non-SP cells. We showed that CNTs induced fibroblastic nodule formation in
primary human lung fibroblast cultures resembling the fibroblastic foci in clinical fibrosis and
promoted FSCs that are highly fibrogenic and a potential driving force of fibrogenesis. The
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developed model could potentially be used as an alternative screening assay to predict the
fibrogenicity of CNTs and other nanomaterials for their safer design and risk assessment.

Key words: Carbon nanotube (CNT), fibroblast stem-like cell (FSC), side population (SP),
collagen I, stemness, fibrogenesis.
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Introduction
Engineered nanomaterials have increasingly been used for a wide array of applications in
the fields as diverse as electronics, aerospace engineering, energy, consumer products, and
medicinal drug delivery. Among them, carbon nanotubes (CNTs) have generated great interest
commercially with their unique physicochemical properties such as high tensile strength and
conductivity [1-3]. The global market for CNTs is estimated to reach a trillion dollars in the next
decade, with their use affecting millions of workers and users [3, 4]. However, despite their
numerous applications, inhalation of these nanoparticles exerts negative effects on the normal
physiological functions of lungs and causes pulmonary toxicity. They are particularly scrutinized
given their high aspect ratio similar to asbestos fibers which induce inflammatory and fibrotic
lung reactions, pleural mesothelioma and lung cancer [4-6]. Unique to CNTs is their nonbiodegradable and biopersistent nature which likely prolongs the fibrotic process. Moreover,
CNT structure facilitates their entry, deposition and residence in the lungs, resulting in impaired
clearance from the lungs [6, 7]. Collectively, these features reinforce the safety concerns about
their pathogenicity and potential adverse effects on the health of exposed workers and the
general population.
At present, human data regarding fibrogenicity assessment of CNTs is lacking and
information on in vivo toxicity is limited, especially for single-walled CNTs (SWCNTs). Initial
findings demonstrated that SWCNTs are capable of causing rapid and progressive interstitial
fibrosis in murine models given their ability to translocate into the surrounding areas in the lung
causing inflammation, granulomatous lesions and sub-pleural fibrosis [8-11].
Classical pulmonary fibrosis is characterized by epithelial cell injury, infiltration of
inflammatory cells, proliferation and transformation of fibroblasts into myofibroblasts,
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irreversible deposition of excessive extracellular matrix (ECM) within the interstitium of the
lung [12]. Given the fibrogenic potential of CNTs, major concern exists about the long-term
human health risks associated with chronic respiratory CNT exposures. The mechanisms
underlying CNT-induced lung fibrosis remain obscure due to the lack of understanding of the
cellular interactions and molecular targets involved. There is evidence suggesting the role of a
multitude of factors including oxidative stress, inflammation, epithelial mesenchymal transition
(EMT), angiogenesis and pro-fibrogenic mediators [13-16]. However, the specific mechanism
underlying CNT-induced fibrosis remains unclear.
Many lung diseases driven by the maladaptive proliferation of myofibroblast cells result
in dysfunctional lung remodeling that affects the regenerative capacity of resident stem cells.
Current paradigms define the origin of these proliferative myofibroblasts as bone marrow,
vascular and epithelium-derived [17]. However, recent studies suggest that stem cells
differentiate into myofibroblasts thereby contributing to tissue fibrosis [18]. In human idiopathic
pulmonary fibrosis (IPF), observational studies suggest dysregulation of a number of epithelial
progenitor cell types, with reactivation of developmental pathways. Despite the potential benefits
of stem cells in lung regeneration and repair, there is no direct evidence for the role of these cells
in parenchymal fibrosis, although there are some circumstantial evidences to support this
possibility [19]. For instance, TGF-β overexpression within the lungs of premature infants
stimulates mesenchymal stem cells (MSCs) to differentiate into myofibroblasts [20], whilst
another study showed that administration of intravenous bone marrow (BM)-derived MSCs
following lung irradiation contributed to fibroblasts and myofibroblasts in areas of damage [21].
Similarly, MSCs isolated from bronchoalveolar lavage fluid (BALF) were found to contribute to
fibrogenesis in human lung allografts [22]. Nearly 80% of collagen-producing lung fibroblasts
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were identified as bone marrow derived in a bleomycin model of pulmonary fibrosis [23],
whereas another study suggested the role of fibroblast precursors and circulating fibrocytes in
lung injury and fibrosis [24]. A recent study of kidney fibrosis showed that 35% of total
myofibroblasts originating from BM-derived MSCs [25]. These findings indicate that stem or
stem-like cells are a critical factor in the development of lung fibrosis. Understanding the
molecular/cellular basis of these cells during lung fibrosis is of critical importance.
Recent findings from our laboratory and other groups have demonstrated that SWCNTs
can directly interact with interstitial lung fibroblasts to exert their direct fibrogenic effects both in
vivo and in vitro in the absence of persistent inflammation and cell damage [26, 26-28]. The
cellular fibrogenic effect of CNTs provides a platform to develop an in vitro fibroblast model for
assessing the fibrogenic potential of CNTs. Therefore, we proposed that fibroblasts can be a
source of stem-like cells upon exposure to CNTs. The primary goal of this study was to
determine the existence of fibroblast stem-like cells (FSCs) upon CNT exposure and studied
their role in CNT-induced fibrogenesis under in vitro settings. This part of the study was focused
on the ability of CNT to induce FSCs.
Rationale:
Recent studies suggest the role of stem cells in the fibroblast to myofibroblast
differentiation and contribution to parenchymal fibrosis. Moreover, previous findings from our
group revealed the expression of universal stem cell markers in human lung fibrotic tissues [29]
as well CNT-induced lung fibrosis tissues, thus providing evidence for the clinical relevance of
stem cells in fibrosis.
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Figure S1: Role of stem-like cells in pulmonary fibrosis
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Experimental Section
SWCNT Preparation
SWCNTs were prepared by plasma purified chemical vapor deposition process and were
obtained from Cheap Tubes Inc. (Brattleboro, VT, USA). They were dispersed in culture
medium containing 5% serum by water-bath sonication. Before exposure to the cells, the
SWCNT dispersion was lightly sonicated (Sonic Vibra Cell Sonicator, Sonic & Material Inc.,
Newtown, CT, USA) with the power, frequency, and amplitude settings of 130 W, 20 kHz, and
60% respectively for 10 s.
Chemicals and Reagents
Antibodies for collagen type I and TGF-β were obtained from Fitzgerald (Concord, MA, USA)
and Cell Signaling Technology, Inc. (Beverly, MA, USA), respectively. β-actin antibody and
horseradish peroxidase (HRP)-conjugated secondary antibodies were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). The antioxidant catalase was obtained from Roche
Molecular Biochemicals (Indianapolis, IN, USA). Antibody for collagen type I was from
Fitzgerald (Acton, MA). Human-derived TGF-β was obtained from R&D Systems (Minneapolis,
MN). Poly-L-lysine and Hoechst 33342 were obtained from Sigma Aldrich (St. Louis, MO).
Antibodies for α-SMA and ALDH1A1 were from Abcam (Cambridge, MA). Antibody for
ABCG2 (BRCP1) was from Milipore (Billerica, MA), and horseradish peroxidase (HRP)conjugated secondary antibodies were obtained from Cell Signaling Technology (Beverly, MA).
DAPI and Alexa Fluor secondary antibodies were obtained from Molecular Probes (Grand
Island, NY).
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Atomic Force Microscopy (AFM) (Some experiments were performed in the laboratory of Dr.
Cerasela-Zoica Dinu)
AFM was used to determine the length and diameter distribution of SWCNT samples using
Digital Instrument Nanoscope II (Model No. MFP-3D-AFM, Asylum Research, Goleta, CA,
USA). A Si tip (50-90 kHz AC240TS, Asylum Research, Goleta, CA, USA) was used to perform
tapping mode in air. SWCNT samples were deposited on mica surfaces (9.5 mm diameter, 0.150.21 mm thickness, Electron Microscopy Sciences, Hatfield, PA USA) and allowed to dry
overnight under vacuum. Scan angel was set as 0, scan rate was set as 0.5 Hz, and resolution was
set as 512. Scan images of 20×20 or 10×10 μm areas were acquired. For each sample, at least 30
individual SWCNT particles were counted and measured to obtain average length and diameter
distribution.
Cell Culture
Normal human lung fibroblasts (NHLFs) were obtained from Lonza (Walkersville, MD, USA).
The cells were maintained in Fibroblast Basal Medium (Lonza, CC-4126, Walkersville, MD,
USA) containing growth supplements. The cells were cultured at 37 °C in 5% CO2 incubator and
were passaged at preconfluent densities using a medium containing 0.05% trypsin.
Cytotoxicity Assay
Cytotoxicity assay was carried out using WST-1 cell viability assay kit (Roche Molecular
Biochemicals, Indianapolis, IN, USA) as per the manufacturer’s instructions. Cells were plated
in triplicate in 96-well plates at the density of 2.0×104 cells/well in CS-C medium. Following
overnight culture, the cells were incubated with the indicated concentrations of SWCNT for 48 h.
After incubation, WST-1 reagent was added and the cells were incubated for an additional 4 h.
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The plates were then read at the wavelength of 420 nm using a microplate reader (Model 3550;
BioRad, Richmond, CA, USA).
Sircol® Collagen Assay
Soluble collagen content was determined by Sircol assay® (Biocolor Ltd., Belfast, UK),
according to the manufacturer’s protocol. Briefly, lung fibroblasts (1×105 cells/well) were
cultured in 6-well plates and treated with SWCNTs of different lengths at the indicated
concentrations for 24 and 48 h. Equal amount of Sirius red reagent (Biocolor Ltd., Belfast, UK)
and cell culture supernatant (50 μL) were added together and mixed for 30 min. The collagendye complex was then precipitated by centrifugation at 13,000× g for 5 min, washed with
ethanol, and dissolved in 0.5 M NaOH. A 200 μL aliquot of the mixture was transferred to a 96well plate and analyzed for optical absorbance at 540 nm.
Isolation of FSC using Flow Cytometry
Cell subsets markedly enriched for stem cell activity are characterized by the ability to efflux the
vital dye Hoechst 33342 via multidrug-like transporter ABCG2. Following appropriate
treatments, the cells were harvested using 0.05% trypsin. Hoechst was added at the final
concentration of 5 µg/ml to stain the cells. Flow cytometry experiments included Hoechststained lung fibroblasts, unstained fibroblasts, and cell suspensions incubated with Hoechst
33342 and the dye uptake inhibitor, fumitremorgin C (FTC). Gates were set according to the
controls. The Hoechst dye was excited with a UV laser and its fluorescence was measured with
both 450/20 filter (Hoechst Blue) and 675 LP filter (Hoechst Red), sorting was performed using
FACS ARIA (BD Biosciences, San Jose, CA, USA).
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Western Blotting
Collagen protein expression was determined by Western blotting. After specific treatments, cells
were incubated in lysis buffer containing 20 mM Tris-HCl (pH 7.5), 1% Triton X-100, 150 mM
sodium chloride, 10% glycerol, 1 mM sodium orthovanadate, 50 mM sodium fluoride, 100 mM
phenylmethylsulfonyl fluoride, and a commercial protease inhibitor mixture (Roche Molecular
Biochemicals, Indianapolis, IN, USA) at 4 °C for 20 min. Cell lysates were collected and protein
concentrations were determined using a bicinchoninic acid protein assay kit (Pierce
Biotechnology, Rockford, IL, USA). Equal amount of protein per sample (40 μg) was resolved
under denaturing conditions by 10% SDS-PAGE and transferred onto a nitrocellulose membrane.
The membranes were blocked for 1 h in 5% nonfat dry milk in TBST (25 mM Tris-HCl, pH 7.4,
125 mM sodium chloride, 0.05% Tween 20) and incubated with appropriate primary antibodies
at 4 °C for 12 h. Membranes were washed thrice with TBST for 10 min and incubated with HRPlabeled isotype-specific secondary antibodies for 1 h at room temperature. The immune
complexes were then detected by enhanced chemiluminescence detection system (Supersignal ®
West Pico, Pierce, Rockford, IL, USA). The bands were quantified via densitometry using Image
J. software, version 10.2 (GraphPad Software Inc., La Jolla, CA, USA). Mean densitometry data
from independent experiments were normalized to results in cells from control experiments.
Growth and Counts of Fibroblastic Nodules
Cells at the density of 3×104 cells/well were seeded onto poly-L-lysine-coated glass cover slips
in 24-well plates and allowed to adhere overnight. The cells were then deprived of serum for 8 h
and then treated with SWCNT, MWCNT, or TGF-β for 16 h, which is the optimal time for
fibroblastic nodule formation. For each culture, three cover slides were analyzed and counted
(Leica Microsystems, Bannockburn, IL) by two independent observers blinded to the treatment.
[41]

Immunofluorescence
For immunofluorescence staining, cells were seeded on rat type I collagen-coated cover slips (5
µg/cm2), fixed with 3.7% paraformaldehyde for 15 min, incubated in 50 mM glycine for 5 min,
permeabilized and blocked with 0.5% saponin, 1.5% BSA, and 1.5% normal goat serum for 30
min. Coverslips were then incubated with the appropriate primary antibodies at 4 °C overnight
followed by secondary Alexa Fluor 488-, 546-, or 647-conjugated antibodies and phalloidin
(Molecular Probes) for 2 h. After washing, cells were mounted on a coverslip using ProLong®
Gold antifade reagent with DAPI (Molecular Probes). Cells were visualized with a Zeiss LSM
510 confocal microscope on an Axiolmager Z1 platform using a 40x objective lens (Carl Zeiss,
Jena, Germany).
Aldehyde Dehydrogenase Assay
Human lung fibroblasts exposed to SWCNT for 24 h were analyzed using an Aldefluor® assay
kit (Stem Cell Technologies, Vancouver, B.C., Canada). Dead cells, cell debris, doublets and
aggregates were excluded by forward and side scattering and pulse-width gating. Cells were
suspended in Aldefluor assay buffer containing ALDH substrate, BODIPY™-aminoacate (BAA)
(1 μM) for 30-60 min per 1×106 cells. After staining cells with the activated Aldefluor® reagent,
the single cell dissociation was maintained on ice during all subsequent procedures. In each
experiment, a sample of cells was stained under identical conditions with 1.5 mM of the specific
ALDH inhibitor diethylaminobenzaldehyde (DEAB) as a negative control. Flow cytometric
sorting was conducted using a FACS ARIA (BD Biosciences, San Jose, CA, USA). Aldefluor
fluorescence was excited at 488 nm, and fluorescence emission was detected using a standard
fluorescein isothiocyanate (FITC) 530/30-nm band-pass filter by a FACS Calibur™ machine
(BD Biosciences, San Jose, CA). High side scatter ALDH+ve and low ALDH−ve were selected.
[42]

Statistical Analysis
The data represent mean ± S.D. from three or more independent experiments. ANOVA was
performed to determine statistical significance between treatment and control groups using
Graph Pad Prism 6.0 (GraphPad Software Inc., La Jolla, CA, USA) at a confidence level of * p <
0.05.

Figure S2: Working model for demonstrating CNT-induced fibroblast stem-like cell induction
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Results
CNT Characterization and Dose Calculation
Pristine SWCNTs were characterized using atomic force microscopy. Table 1 provides
information on the purity, length and diameter characteristics for the SWCNTs used in this study.
SWCNTs differed slightly in their diameter and their length both in the solution and dry forms
with a specific surface area of 407 m2/g. SWCNTs were dispersed using serum and were lightly
sonicated prior to culture exposure. The SWCNT doses used in the in vitro exposure studies were
calculated based on in vivo CNT exposure data normalized to alveolar surface area in mice [29].
The doses that induced positive in vivo fibrogenic response were 10-80 μg/mouse lung (0.5
mg/kg body weight) [30-32]. Dividing this dose by the average alveolar surface area in mice
(∼500 cm2) [32] indicates the in vitro surface area dose of 0.02-0.16 μg/cm2.
Effect of SWCNTs on Cell Viability and Type I Collagen Expression
Cultured normal human lung fibroblasts were exposed to SWCNTs and analyzed for cellular
toxicity (Figure 3). This study was performed to optimize the experimental doses of SWCNT
that are relevant to in vivo lung fibrosis. Lung fibroblasts were treated with different
concentrations of SWCNT for 48 h and analyzed for cell viability by WST-1 assay (Figure 3A).
The doses of 0.02-0.6 μg/cm2 were used in this study since they are physiologically relevant and
derived from pulmonary exposure data in mice, i.e., 10-80 μg/mouse which corresponds to 0.020.16 μg/cm2 of mouse lung alveolar surface area [9, 27, 28]. SWCNTs induced a dose-dependent
decrease in cell viability of the cultured fibroblasts. We also investigated the collagen-inducing
effect of SWCNTs in lung fibroblasts. To avoid the interfering effect of cell toxicity on
collagenic activity of the cells, we performed experiments using low non-cytotoxic doses of
SWCNT (Figure 3B, 3C). SWCNTs induced a substantial increase in collagen expression as
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determined by Western blot assay. Analysis of soluble collagen content by Sircol ® assay
confirmed the fibrogenic effect of SWCNTs (Figure 3D)
CNTs Induce Side Population Phenotype of Lung Fibroblasts
Adult stem cells are known to efflux Hoechst dye slowly due to their high expression of ABCG2.
Flow cytometric analysis was used to identify these stem cells with a distinct low Hoechst
staining pattern referred to as side population (SP) [33, 34]. An increase in SP population was
reported in the lung of mice with fibrosis, suggesting the involvement of SP-positive stem cells
in lung fibrogenesis [25]. To determine the potential role of stem-like fibroblasts in CNTinduced fibrogenesis, we first determined the change of SP subpopulation upon CNT treatment.
Primary human lung fibroblasts were treated with SWCNT at the concentration of 0.15 μg/cm2
for 48 h, after which they were incubated with 5 μg/mL of Hoechst 33342 in the presence or
absence of 25 μM fumitremorgin C (FTC), an inhibitor of ATP- binding cassette (ABC)
transporter (Figure 4A). SWCNTs were able to induce the SP subpopulation and the percentage
of SP was approximately 5% in SWCNT-treated fibroblasts versus less than 0.5% in vehicletreated control cells (Figure 4B). We also tested the expression of α-SMA, the myofibroblast
marker in CNT-induced SP fibroblasts. SP cells overexpressed α-SMA compared to non-SP
cells, suggesting the fibroblast to myofibroblast transition in both SW and MWCNT-induced
stem-like fibroblasts (Figure 4C).
Side Population is a Potential Source of Collagen I and alpha-SMA
Increased α-SMA is a characteristic feature indicating the transformation of fibroblasts to
myofibroblasts, which is known to be the main source of collagen production [12]. To determine
whether isolated SP and non-SP were able to induce myofibroblast phenotype, we isolated the
stem-like cells from SWCNT-treated (0.15 μg/cm2) fibroblasts based on their SP phenotype
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using flow cytometry based cell sorting (Figure 5A). Sorted SP and non-SP fibroblasts were
further evaluated for collagen I and α-SMA expression. Figures 5B and 5C reveal a substantially
higher expression of collagen I and SMA in the SP versus non-SP cells, thus confirming that SP
fibroblasts could be key originating sources of collagen production and the myofibroblasts, and
may play a crucial role in fibrogenesis.
Increased Stem Cell Marker and Collagen Expression in CNT-Derived SP Fibroblasts
Recent studies indicate the functional role of stem cells at the early onset of pulmonary fibrosis.
To determine the role of stem-like fibroblasts in CNT-induced fibrogenesis, we isolated the
stem-like cells from SWCNT-treated (0.15 μg/cm2) fibroblasts based on their SP phenotype as
earlier described. Sorted SP and non-SP fibroblasts were further evaluated for the universal stem
cell marker ABCG2 [35] and type I collagen expression by immunofluorescence (Figure 6).
Figures 6A, 6B reveals a substantially higher expression of ABCG2 in the SP versus non-SP
cells, thus confirming the stem-like phenotype of SP fibroblasts and the reliability of stem cell
isolation by FACS. Importantly, type I collagen expression was significantly higher in the SP
versus non-SP population. It is widely known that fibroblasts play a key role in fibrogenesis
through its ability to synthesize and secrete ECM proteins including type I collagen, which
characterizes fibrosis [36, 37]. Our results thus reveal the potential role of SP cells in
fibrogenesis via simultaneous expression of stem cell and fibrosis markers. Furthermore, the
increases in stem cell markers ABCG2 and ALDH1A1 via immunofluorescence [35, 38] were
validated via Western blotting (Figure 6C, 6D).
CNTs Induce Fibroblastic Nodule Formation of Human Lung Fibroblasts
Formation of fibrotic nodules has been described as a means to quantify fibrosis and to screen
anti-fibrotic agents [39, 40]. Fibrotic nodules are deﬁned by a collagenous core with an
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accumulation of extracellular matrix and a bounding cell layer detached from the alveolar wall
[41, 42]. In this part of the study we tested whether SP cells are capable of forming fibrous
nodules in a 3D in vitro model as compared to non-SP cells. A 3D biomimetic model of
fibroblastic foci was developed by growing primary human lung fibroblasts in culture on a polyL-lysine substrate, while TGF-β was used as a positive inducer of fibrosis (Figure 7). The
formation of 3D cell clusters that are referred to as fibroblastic nodules after treatment of the
cells with TGF-β (1 ng/mL) for 16 h. Interestingly, treatment of the cells with SWCNT induced
the fibroblastic nodules, whereas vehicle-treated control cells showed minimal nodule formation
(Figure 7A). Quantitative analysis for the number of fibroblastic nodules demonstrated the dosedependent effect of SWCNT treatment (Figure 7B). To substantiate the functional role of stemlike fibroblasts in CNT fibrogenesis, the sorted SP and non-SP cells from CNT-treated
fibroblasts were assessed for their ability to form fibroblastic nodules. SP cells had a
substantially higher capability to form fibroblastic nodules than the non-SP fibroblasts (Figure
7C). Altogether, these findings support the role of stem-like fibroblasts in CNT-induced
fibrogenesis.
Supplemental Data
CNTs Induce Fibroblast-Stem Cells in a Dose and Cell Type-Dependent Manner
To determine if CNT-induced stem-like fibroblast generation was dose dependent, the doses of
0.02-0.2 μg/cm2 were used since they are physiologically relevant and derived from pulmonary
exposure data in mice (Figure 8A). SWCNTs induced a dose-dependent FSC induction
correlating with the collagen I and α-SMA response of the cultured fibroblasts (Figure 8B). In
order to optimize the time of exposure to CNTs and the resulting SP generation, cultured lung
fibroblasts were exposed to SWCNTs at 24, 48, and 72 h time points. 48 h exposure was found
[47]

to be critical for SWCNT-driven stem-like fibroblast induction (Figure 8C). Nanomaterialmediated cell toxicity has been shown to vary depending upon the cell type that the material
interacts with. To investigate if SP generation was cell type dependent, using three different
models for lung fibroblasts (primary normal human lung fibroblasts, 3T3 mouse embryonic lung
fibroblasts, and WI-38 human lung fibroblasts), SP generation was found to be cell type
dependent (Figure 8A, 8B, 8C). These findings demonstrated that CNT dose, exposure time and
exposed cell type are key determinants for the resulting stem-like fibroblast induction.
CNT-Induced FSC Generation Using Aldehyde Dehydrogenase (ALDH) Expression as a Marker for
Stem-like Cells

A high level of ALDH activity serves as a functional marker for stem/progenitor cells and allows
for simple, efficient isolation of cells with primitive features [43]. Human stem and progenitor
cells typically have more ALDH activity than mature cells, and this quantitative difference
allows stem cells to be resolved from other cells [44]. Lung fibroblasts were treated with
SWCNT at 0.15 μg/cm2 for 24 h after which they were incubated with 0.3 mM activated
Aldeflour dye in the presence or absence of 1.5 mM ALDH inhibitor, diethylaminobenzaldehyde
(DEAB) (Figure 10). SWCNT induced ALDH positive (+ve) cells indicated by the ALDH Hi
fraction (Figure 10A) and the percentage of ALDH +ve population of cells was approximately 6
% in SWCNT-treated fibroblasts versus less than 0.5% in vehicle-treated control cells (Figure
10B).
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Discussion
Currently, there is an urgent need for efficient in vitro models for fibrogenicity testing of
nanomaterials. The large and rapidly expanding number of engineered nanomaterials makes it
impossible to test them all in animals due to time constraints and prohibitive cost [45]. In this
study, we developed and tested a fibroblast cell assay as a rapid, low cost, predictive in vitro
model that demonstrates stem-like cell induction as a mechanism critical for the development of
lung fibrosis.
Fibrosis is a progressive disorder associated with abnormal wound healing, excessive
collagen deposition and ECM accumulation [12, 46]. Identifying the cells that are capable of
repairing the injured tissue and are the source of ECM production is fundamental to the
understanding of fibrosis mechanisms. Recent studies have indicated the pathogenic role of stem
and progenitor cells in pulmonary fibrosis at the early onset of lung fibrosis in murine models
[20-25]. The fibrogenic potential of CNTs has been well documented [8-11, 13-16]; however, the
concept of stemness in the light of nanomaterial-induced fibrosis has not been explored. Since
fibroblasts are known to induce collagen and ECM deposition, which are hallmarks of fibrosis
[26, 27, 45], the present study was designed to investigate whether CNT exposure in lung
fibroblasts can induce FSCs and whether these stem-like cells possess fibrogenic activities. FSCs
were induced by exposing primary human lung fibroblasts to CNTs. These cells were used in this
study because they are of human origin and a better representation of pathological process than
immortalized cell lines that are popularly used but may possess defective genes affecting fibrosis
development. Our results demonstrated FSC generation from normal lung fibroblasts postSWCNT exposure. The isolated FSCs from FACS analysis were further characterized for
potential fibrosis and stem cell markers to determine their putative role in fibrogenesis.
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To optimize the experimental doses of SWCNT that are relevant to in vivo lung fibrosis,
lung fibroblasts were treated with different concentrations of SWCNT for 48 h and analyzed for
cell viability by WST-1 assay. The doses of 0.02-0.2 μg/cm2 were used in this study since they
are physiologically relevant and derived from in vivo pulmonary exposure data in mice, i.e., 1080 μg/mouse corresponding to mouse lung alveolar surface area [9, 27, 28]. The collageninducing effect of SWCNTs was not due to their proliferative activity since fibroblast cell growth
was not increased by the SWCNT treatment as indicated by WST-1 assay. An increased
expression of the myofibroblast marker α-SMA in SWCNT-treated cells indicated the
transformation of fibroblasts to myofibroblasts, and their production of extracellular matrix
proteins [47, 48].
We demonstrated the existence of FSCs as evidenced by the SP phenotype of lung
fibroblasts post-CNT exposure. SWCNT treatment produced a significantly higher percentage of
SP population, thereby signifying the potential role of stem-like fibroblasts in CNT-induced
fibrogenesis. CNT-induced SP upregulated both collagen I and α-SMA compared to the non-SP,
indicating that the stem-like fibroblasts are a potential key source of collagen production and
may play a crucial role in fibrogenesis. Furthermore, the elevated expression of stem cell
markers, ABCG2 and ALDH1A1, in SP versus non-SP cells as evidenced by Western blotting
and immunofluorescence confirmed the stem phenotype of SP fibroblasts and the reliability of
our employed method of stem cell isolation via FACS.
An important pathological feature of human lung fibrosis is the presence of fibroblastic
foci, which are aggregates of lung fibroblasts and myofibroblasts and the newly deposited
collagen [39-41]. Here we verified the in vitro model of CNT-induced fibroblastic nodule
formation that correlates the development of stem cell phenotype and onset of fibrosis. Using
[50]

fibroblastic nodule generation as a model for lung fibrosis has the following advantages: (i)
clinical resemblance to human lung fibrotic lesions; (ii) rapid and quantitative or semiquantitative analysis, (iii) fewer cell numbers needed per assay; and (iv) potential for highthroughput screening [29]. SWCNT treatment induced a dose-dependent fibrotic nodule
formation which also correlated with the SWCNT dose-driven collagen expression observed in
Figure 2A. Furthermore, SP fibroblasts demonstrated higher potency in fibroblastic nodule
generation compared to non-SP fibroblasts, hence supporting their key role in fibrogenesis.
Although considerable experimental data related to CNT toxicity at the cellular and
whole animal levels have been published, the results are often conflicting [49]. Therefore, a
systematic understanding of CNT toxicity in terms of different cell lines and animal species,
multidimensional evaluation methods, and exposure conditions is needed but has not yet been
developed. In agreement with other studies, we demonstrated that stemness phenotype is cell
line, dose and time-dependent, indicating that the dose and exposure time of SWCNT are critical
for stemness induction. To obtain accurate results, future studies must establish standards and
reliable detection methods, use standard CNT samples as a reference control, and study the
impact of various factors systematically.
The Aldeflour™ detection system is an alternative method to side population assay to
identify human stem/progenitor cells on the basis of their ALDH activity. Using ALDH as a
marker for stem cells, we validated the stem cell phenotype of SWCNT-induced FSCs as
indicated by the significantly increased ALDH activity in SWCNT-treated cells compared to
untreated controls.
In summary, we have developed an in vitro model for CNT-induced lung fibrosis
involving CNT-driven FSC generation and studied their putative role in fibrogenesis. The
[51]

isolated FSCs were found to be key sources of collagen I and α-SMA, whereby they may play a
crucial role in fibrogenesis. Besides being potential sources of collagen production, stem-like
fibroblasts substantially elevated the expression universal stem cell markers including ABCG2
and ALDH1A1, validating the SP phenotype model of CNT-induced lung fibrogenesis. SP lung
fibroblasts were potent in fibroblastic nodule formation compared to the non-SP cells supporting
their key role in fibrogenesis. The developed model could potentially be used as an alternative
assay to predict the fibrogenicity of CNTs and other nanomaterials for their safer design and risk
assessment. The novel role of FSCs in CNT-induced collagen production and α-SMA expression
provides new insights into the mechanisms of pulmonary fibrosis. In addition, the findings from
this study could potentially benefit in the development of early detection biomarkers and
treatment strategies for the disease.

Figure S3: Proposed mechanisms of CNT-induced lung fibrosis
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Figures
Purity

>99%

Length
Solution Form
(μm)
12.71±0.48

Diameter
Dry Form
(μm)

(nm)

12.9±0.55

18.76±8.62

Table 1: Physicochemical Characterization of SWCNTs. The
table describes the purity, diameter and length distribution
measured via AFM.

B

Figure I: Carbon nanotubes (CNT) induce collagen production of human lung fibroblasts
Subconfluent monolayers of cells were treated with various concentrations (0-0.2 μg/cm2) of
SWCNT, or TGF-β (1 ng/mL) for 48 h. A) Analysis of cell toxicity and proliferation using
WST-1 assay. B) Western blot analysis of type I collagen and α-SMA. β-actin was used to
confirm equal loading of the samples. C and D) Quantitative analysis of type I collagen and α[57]

SMA. E) Soluble collagen content by Sircol assay. Data are means ± SD (n =3). *p < 0.05 versus
control cells.
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Figure II: CNT induce stem-like cells as indicated by side population (SP) phenotype
A) SWCNT-treated human lung fibroblasts isolated into SP and NSP with and without the
inhibitor fumitremorgin C (FTC) as indicated by the % population. B) % SP population in
SWCNT and MWCNT-treated lung fibroblasts as compared to vehicle-treated control. C)
Relative fold change in α-SMA expression (SP versus non-SP cells) in CNT-treated cells
compared to vehicle-treated control. D) Data are means ± SD (n =3). *p < 0.05 versus control
cells.
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Figure III: CNT-induced SP fibroblasts are a potential source of collagen I and α-SMA
A) SWCNT-treated human lung fibroblasts isolated into SP and NSP with and without the
inhibitor fumitremorgin C (FTC) as indicated by the % population. B) Quantitative analysis of %
SP population in SWCNT and MWCNT-treated lung fibroblasts. C) Type I collagen and α-SMA
expression in SWCNT-induced SP versus non-SP cells. D) Quantitative analysis of type I
collagen and α-SMA. Data are means ± SD (n =3). *p < 0.05 versus Non-SP cells.
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Figure IV: Enhanced fibrogenic response of CNT-derived SP fibroblasts
Cells were treated with SWCNT (0.15 μg/cm2) for 48 h and stained with Hoechst 33342 dye for
side population (SP) analysis. SP fibroblasts were characterized and isolated by FACS. A)
Fluorescence micrographs of the sorted SP fibroblasts and parental control non-SP fibroblasts
immunostained for phalloidin (F-actin, green), stem cell marker ABCG2 (red), and type I
collagen (yellow) by confocal fluorescence microscopy. B) Quantitative analysis of ABCG2 and
type I collagen expression. C) ABCG2 and ALDH1A1 stem cell marker expression in CNTinduced SP versus non-SP stem-like fibroblasts. D) Quantitative analysis of type I collagen and
α-SMA. Data are means ± SD (n =3). *p < 0.05 versus Non-SP fibroblasts.
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Figure V: CNT induce fibroblast nodule formation of human lung fibroblasts
Cells at the density of 3×104 cells/24-well were grown on a poly-L-lysine-coated glass substrate
and treated with various concentrations (0-0.15 μg/cm2) of SWCNT or TGF-β (1 ng/mL) for 16
h. A) Phase contrast micrographs comparing 3D fibroblastic nodules in control and treated
fibroblasts. B) Quantitative analysis of fibroblastic nodules in SWCNT and TGF-β treated lung
fibroblasts versus control. C) Quantitative analysis of fibrotic nodules in SWCNT-induced SP
versus non-SP cells. Data are means ± SD (n =3). #p<0.05 versus control cells; *p < 0.05 versus
SP fibroblasts.
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Figure VI: CNT-induced SP is dose dependent
SWCNT induced stem-like cells as indicated by side population (SP) phenotype in a dosedependent manner. A) Primary lung fibroblasts were treated with SWCNT (0-0.20 μg/cm2) for
48 h and stained with Hoechst 33342 dye for side population (SP) analysis as indicated by the %
population. SP fibroblasts were characterized and isolated by FACS. B) Quantitative analysis of
% SP population in SWCNT-treated lung fibroblasts. Data are means ± SD (n =3). *p < 0.05
compared to control cells.
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Figure VII: CNT induced SP is cell type-dependent
Fibroblast cells were treated with SWCNT (0.15 μg/cm2) for 48 h and stained with Hoechst
33342 dye for side population (SP) analysis with and without the inhibitor fumitremorgin C
(FTC). Representative FACS micrographs showing A) % SP population in SWCNT-treated
primary human lung fibroblasts as compared to vehicle-treated control, B) % SP population in
SWCNT-treated 3T3 mouse lung fibroblasts as compared to vehicle-treated control, and C) % SP
population in SWCNT-treated WI 38 human lung fibroblasts as compared to vehicle-treated
control.
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Figure VIII: CNT upregulate ALDH activity of lung fibroblasts
A) WI 38 human lung fibroblasts were treated with SWCNT (0.15 μg/cm2) for 24 h and stained
with Aldeflour dye in the presence or absence of 1.5 mM ALDH inhibitor,
diethylaminobenzaldehyde (DEAB) for ALDH activity analysis. Cells with increased ALDH
activity were characterized and isolated by FACS. B) Quantitative analysis of % ALDH activity
in SWCNT-treated lung fibroblasts compared to control. Data are means ± SD (n =3). *p < 0.05
compared to control cells.
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CHAPTER 3
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CHAPTER 3: ROLE OF REACTIVE OXYGEN SPECIES IN STEMNESS
DEVELOPMENT AND FIBROGENESIS INDUCED BY CARBON NANOTUBES
Abstract
The unique physicochemical and electrical properties of carbon nanotubes (CNTs) make them
highly desirable in a variety of commercial and biomedical applications. However, these novel
properties of CNTs are fraught with concerns for environmental and occupational exposure.
Changes in their structural and physicochemical properties can lead to changes in biological
activities including reactive oxygen species (ROS) generation; one of the most frequently
reported CNT-associated toxicities. CNT exposure results in ROS-dependent activation of
several transcription factors and signaling pathways involved in the regulation of inflammation
and fibrosis. ROS are known to regulate several cellular responses such as collagen production,
fibroblast to myofibroblast activation, and angiogenesis implicated in CNT-induced fibrosis. We
have previously demonstrated the existence of fibroblast stem-like cells (FSCs) and their role in
CNT-induced fibrogenesis. It is unknown whether CNT-induced oxidative stress is essential for
the development of stemness phenotype of FSCs. We hypothesized that this process is under the
regulation of ROS and that such stemness phenotype is essential to the fibrogenic activity of
FSCs that contributes to fibrosis. Normal human lung fibroblasts were treated with single-walled
CNTs in the presence or absence of various known ROS modulators, and FSCs were identified
by their side population (SP) and isolated by fluorescence activated cell sorting (FACS). Our
results demonstrated that i) SWCNTs induced ROS generation in human lung fibroblasts, ii)
such induction, particularly peroxides, are required for the generation of FSCs, iii) the fibrogenic
activity of these FSCs is under the regulation of ROS, iv) effect of fiber length and surface
modification on SWCNT-induced oxidative stress, and v) SWCNT-induced FSCs exhibited
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substantial downregulation of antioxidant enzymes including catalase, glutathione peroxidase
and superoxide dismutase. These findings indicate a novel mechanism of CNT fibrogenesis
regulation through ROS-dependent induction of FSCs, which may be targeted for disease
intervention.
Keywords: Reactive oxygen species (ROS), fibrosis, fibroblast stem-like cell (FSC), N-acetyl
cysteine (NAC), oxidative stress, SWCNT
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Introduction
Uncontrolled regulation of reactive oxygen species (ROS) generation has been implicated
in the pathogenesis of several diseases including lung inflammation and fibrosis.[1, 2] Increased
ROS generation leading to oxidative stress and cellular damage is one of the most frequently
reported toxicity endpoints caused by carbon nanotube (CNT) exposure.[3-6] Oxidative stress
may be caused directly by CNT-induced ROS in the vicinity or inside the cell, or indirectly due
to the effect of internalized CNTs on mitochondrial respiration [7, 8] or depletion of ROS
scavengers and antioxidant enzymes within the cell.[9] Incomplete phagocytosis of CNTs,
presence of transition metals such as iron, cobalt and nickel introduced within the CNTs during
their synthesis, and specific reactive groups on the CNT surface are key drivers of ROS
generation.[7, 10, 11] Nanoparticle-induced ROS responses have been reported to orchestrate a
series of pathological events such as genotoxicity [12, 13], inflammation [14], fibrosis [5, 15],
and carcinogenesis.[16] For instance, CNT-induced oxidative stress triggers cellular signaling
pathways such as NF-κB, STAT-1, MAPK, and RTK resulting in increased expression of proinflammatory and fibrotic cytokines.[15, 17-20] CNT-induced ROS generation has also been
shown to regulate several cellular events such as collagen production, fibroblast to myofibroblast
transition, and angiogenesis, which have been implicated in the pathogenesis of lung fibrosis.[5,
15, 21] Previous studies by our group also indicate the involvement of ROS in CNT-induced
fibrogenesis. [15, 22] We demonstrated the pathogenic role of fibroblast stem-like cells (FSCs)
in SWCNT-induced fibrogenic response in chapter 1. Recent studies indicate the differentiation
of stem cells into myofibroblasts and their contribution to tissue fibrosis.[23-25] Interestingly,
ROS have been shown to play an essential role in the fate and physiology of normal stem cells;
there is evidence demonstrating that ROS production promotes proliferation and survival of both
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stem and progenitor cells.[26] Currently, there is no information linking CNT-induced oxidative
stress and stemness development. This study was undertaken, in part, to evaluate whether CNTinduced oxidative stress is essential for the development and maintenance of stemness phenotype
of FSCs during SWCNT-induced fibrogenesis.
The relationship between ROS and stem cell development is not well understood,
although ROS have been suggested to play a role in the differentiation and maintenance of stem
cells.[27] ROS and antioxidants are essential to maintain a redox balance within cells and tissues.
Many cellular processes including proliferation, differentiation, apoptosis, and response to injury
are governed via intracellular ROS.[28] The redox environment is particularly important for stem
cell differentiation and self-renewal.[29] Low ROS level within stem cells has been reported to
maintain their stemness, whereas a high level promotes differentiation, proliferation and
survival.[30] However, normal stem cells are generally thought to maintain low ROS level to
protect against damage.[31] High ROS levels are detrimental to cells and tissues. As a result, just
as oxidative stress is associated with multiple disorders; elevated ROS levels have been
implicated in the progression of stem cell-associated pathologies.[27] For instance, ROS promote
stem cell expansion in colorectal cancer.[32] Increased oxidative status has been shown to drive
stem cell activity of neuroepithelial and skin stem cells.[33, 34] Currently, stem cells continue to
be pursued as potential therapy for regeneration and tissue repair; however, they have both
adaptive and maladaptive responses to oxidative stress. For example, acute bursts of ROS to
embryonic stem cells (ESCs) in culture facilitate differentiation toward cardiomyocyte
phenotype, whereas prolonged exposure to H2O2 inhibits differentiation.[35] The effect of ROS
has been reasonably studied in certain stem cell types; however their effect on the differentiation
of stem-like cells into myofibroblasts during lung fibrosis is not known. Whether oxidative stress
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drives the stem-like cell induction associated with CNT-induced fibrosis remains to be explored.
Unveiling such regulation could lead to the identification of novel biomarkers or drug targets for
disease treatment and prevention. We hypothesized that ROS are involved in the development of
fibroblast stem-like cells during CNT-induced fibrosis. In this part of the study, we investigated
whether ROS regulate the stem phenotype of lung fibroblasts during CNT exposure and
identified the specific ROS important for the stemness development.
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Experimental Section
SWCNT Preparation
SWCNTs were prepared by plasma purified chemical vapor deposition process and were
obtained from Cheap Tubes Inc. (Brattleboro, VT, USA). They were dispersed in culture
medium containing 5% serum by water-bath sonication. Before exposure to the cells, the
SWCNT dispersion was lightly sonicated (Sonic Vibra Cell Sonicator, Sonic & Material Inc.,
Newtown, CT, USA) with the power, frequency, and amplitude settings of 130 W, 20 kHz, and
60% respectively for 10 s.
Chemicals and Reagents
Antibodies for collagen type I and TGF-β were obtained from Fitzgerald (Concord, MA, USA)
and Cell Signaling Technology (Beverly, MA, USA), respectively. β-actin antibody and
horseradish peroxidase (HRP)-conjugated secondary antibodies were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). Mn (III) tetrakis (4-benzoic acid) porphyrin (MnTBAP)
was obtained from Calbiochem (La Jolla, CA). Catalase (CAT) was from Roche Molecular
Biochemicals (Indianapolis, IN). The oxidative probes, dichlorodihydrofluorescein diacetate
(DCF-DA) and dihydroethidium (DHE) were from Molecular Probes (Eugene, OR). All other
chemicals and reagents including N-acetyl cysteine (NAC) were from Sigma-Aldrich (St. Louis,
MO).
Energy Dispersive X-ray Spectroscopy (EDX-S) (Some experiments were performed in the
laboratory of Dr. Cerasela-Zoica Dinu)
EDX-S was used to perform elemental analysis of SWCNT samples. Data were collected on a
LEO 1530 VP scanning electron microscope equipped with an energy-dispersive X-ray analyzer
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(Hitachi S-4700 Field Emission Scanning Electron Microscope, Hitachi High Technologies Co.,
Tokyo, Japan). A few drops of SWCNT dispersion in cell culture medium were placed on a
silicon wafer and allowed to air-dry. The silicon wafer was then mounted on an aluminum stub
for EDX-S analysis.
Atomic Force Microscopy (AFM) (Some experiments were performed in the laboratory of Dr.
Cerasela-Zoica Dinu)
AFM was used to determine the length and diameter distribution of SWCNT samples using
Digital Instrument Nanoscope II (Model No. MFP-3D-AFM, Asylum Research, Goleta, CA,
USA). A Si tip (50-90 kHz AC240TS, Asylum Research, Goleta, CA, USA) was used to perform
tapping mode in air. SWCNT samples were deposited on mica surfaces (9.5 mm diameter, 0.150.21 mm thickness, Electron Microscopy Sciences, Hatfield, PA, USA) and allowed to dry
overnight under vacuum. Scan angel was set as 0, scan rate was set as 0.5 Hz, and resolution was
set as 512. Scan images of 20×20 or 10×10 μm areas were acquired. For each sample, at least 30
individual SWCNT particles were counted and measured to obtain average length and diameter
distribution.
Cell Culture
Normal human lung fibroblasts (NHLFs) were obtained from Lonza (Walkersville, MD, USA).
The cells were maintained in Fibroblast Basal Medium (Lonza, CC-4126) containing growth
supplements. The cells were cultured at 37 °C in 5% CO2 incubator and were passaged at
preconfluent densities using a medium containing 0.05% trypsin.
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Isolation of FSCs using Flow Cytometry
Cell subsets markedly enriched for stem cell activity are characterized by their ability to efflux
the vital dye Hoechst 33342 via multidrug-like transporter ABCG2. After specific treatments,
cells were harvested using 0.05% trypsin and stained with Hoechst dye at the final concentration
of 5 µg/ml. Flow cytometry experiments included Hoechst-stained lung fibroblasts, unstained
fibroblasts, and cell suspensions incubated with Hoechst 33342 and the dye uptake inhibitor,
fumitremorgin C (FTC). Gates were set according to the controls. The Hoechst dye was excited
with a UV laser and its fluorescence was measured with both 450/20 filter (Hoechst Blue) and
675 LP filter (Hoechst Red), sorting was performed using FACS ARIA (BD Biosciences, San
Jose, CA, USA).
Western Blot Analysis
Collagen protein expression was determined by Western blotting. After specific treatments, cells
were incubated in lysis buffer containing 20 mM Tris-HCl (pH 7.5), 1% Triton X-100, 150 mM
sodium chloride, 10% glycerol, 1 mM sodium orthovanadate, 50 mM sodium fluoride, 100 mM
phenylmethylsulfonyl fluoride, and a commercial protease inhibitor mixture (Roche Molecular
Biochemicals, Indianapolis, IN, USA) at 4 °C for 20 min. Cell lysates were collected and protein
concentrations were determined using a bicinchoninic acid protein assay kit (Pierce
Biotechnology, Rockford, IL, USA). Equal amount of protein per sample (40 μg) was resolved
under denaturing conditions by 10% SDS-PAGE and transferred onto a nitrocellulose membrane.
The membranes were blocked for 1 h in 5% nonfat dry milk in TBST (25 mM Tris-HCl, pH 7.4,
125 mM sodium chloride, 0.05% Tween 20) and incubated with appropriate primary antibodies
at 4 °C for 12 h. Membranes were washed thrice with TBST for 10 min and incubated with HRPlabeled isotype-specific secondary antibodies for 1 h at room temperature. The immune
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complexes were then detected by enhanced chemiluminescence detection system (Supersignal ®
West Pico, Pierce, Rockford, IL, USA). The bands were quantified via densitometry using Image
J software, version 10.2 (GraphPad Software Inc., La Jolla, CA, USA). Mean densitometry data
from independent experiments were normalized to results in cells from control experiments.
Fluorometric Assay for ROS Detection
Intracellular ROS was determined fluorometrically using DCF-DA and DHE as fluorescent
probes. After treatment with SWCNTs, the cells were incubated with the probes (5 mM) for 30
min at 37 °C, after which they were analyzed for fluorescence intensity using a multi-well plate
reader
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Durham,
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at
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excitation/emission wavelengths of 485/535 and 485/610 nm for DHE and DCF fluorescence
measurements, respectively.
Statistical Analysis
The data represent mean ± S.D. from three or more independent experiments. ANOVA was
performed to determine statistical significance between treatment and control groups using
Graph Pad Prism 6.0 (GraphPad Software Inc., La Jolla, CA, USA) at a confidence level of * p <
0.05.
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Results
Effect of SWCNTs on Cellular Oxidative Stress
Since oxidative stress has been implicated as an underlying mechanism for pulmonary fibrosis
[36], we investigated the effect of SWCNTs on cellular ROS generation as an indicator of
oxidative stress. Cells were treated with SWCNTs and analyzed for ROS generation by
fluorometry using DCF-DA and DHE as fluorescent probes for hydrogen peroxide and
superoxide radicals, respectively (Figure 1). SWCNTs induced a dramatic increase in cellular
DCF fluorescence intensities, indicative of peroxide formation (Figure 1A), but had negligible
effect on DHE fluorescence, indicative of superoxide formation (Figure 1B). Pretreatment of the
cells with general antioxidant N-acetyl cysteine (NAC) strongly inhibited the ROS-inducing
effect of SWCNTs (Figure 1A). Likewise, pretreatment of the cells with catalase, a peroxide
scavenger, effectively inhibited the ROS generation (Figure 1A), indicating the induction of
peroxides by SWCNTs and the specificity of peroxide detection by DCF fluorescence
measurements in the tested cell system. Figure 1B shows the inhibitory effect of MnTBAP, a
superoxide scavenger, on SWCNT-induced DHE fluorescence, confirming the specificity of
superoxide detection and the limited induction of superoxide anions by SWCNTs. Together,
these results indicate the ROS-inducing effect of SWCNTs, particularly peroxides, in cultured
human lung fibroblasts.
Effect of Length and Surface Modification on SWCNT-Induced ROS Generation
Certain physicochemical properties of nanoparticles (NPs), such as prooxidant functional groups
and surface activity, have been suggested as key determinants of NP-induced ROS
generation.[37, 38] In this study, we further investigated the effect of fiber length and
functionalization on SWCNT-induced ROS generation. Lung fibroblasts were treated with
[76]

SWCNTs of different lengths and functionalities, and analyzed for ROS generation by
fluorometry. As compared to pristine, non-functionalized (NF) SWCNTs of similar length, the
modified SWCNTs, including COOH, nitrogen-containing and OH elicited a weaker ROS
response (Figure 2A). Both short and long SWCNTs induced ROS generation as indicated by
their increased cellular DCF fluorescence intensities over control level. However, long SWCNTs
were more potent inducers of ROS generation compared to short SWCNTs (Figure 2B). In all
experiments, pretreatment of the cells with NAC or catalase strongly inhibited the DCF
fluorescence signals (Figure 2A, 2B), indicating the general ability of SWCNTs of different
lengths and surface modifications to induce ROS.
Role of ROS in SWCNT-Induced Fibrogenesis
Oxidative stress signaling has been linked to excessive accumulation of extracellular matrix
(ECM).[39] Previous work from our group demonstrated that CNTs induce a ROS-dependent
fibrogenic effect on lung fibroblasts by upregulating collagen expression and cell
proliferation.[15] To determine the role of ROS in SWCNT-induced fibrogenic effect, fibroblasts
were treated with SWCNTs of various lengths and surface modifications in the presence or
absence of the antioxidant NAC. All forms of SWCNTs were able to induce collagen expression
with the unmodified CNTs being most potent (Figure 3A, 3C). Long SWCNTs induced a more
robust collagen response than short SWCNTs (Figure 3B, 3D). Moreover, NAC pretreatment
abrogated the collagen-inducing effect of all forms of SWCNTs, supporting the role of ROS in
SWCNT-induced fibrogenesis.
Role of ROS in CNT-Induced Fibroblast Stem-like Cell (FSC) Generation
Previous studies have identified a stem-like side population (SP) of cells using flow
cytometry.[40, 41] SP is the cell population identified by its capacity to efflux Hoechst dye that
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is highly enriched for stem/progenitor cell activity. SP cells appear “off to the side” of the main
population of cells due to their relative absence of staining.[42] Our previous study from chapter
1 demonstrated the ability of SWCNTs to induce stem-like fibroblasts as evidenced by their side
population phenotype. Furthermore, these cells also express stem cell markers, including
ALDH1A1 and ABCG2. In order to determine the role of ROS on stemness induction, human
lung fibroblasts were treated with SWCNTs with or without antioxidant pretreatment, and
subsequently sorted into SP and NSP by FACS. NAC and catalase pretreatment significantly
inhibited SP induced by SWCNTs, whereas superoxide scavenger MnTBAP pretreatment had
minor effect (Figure 4A, 4B), supporting the role of peroxides in the induction of FSCs by
SWCNTs.
Role of ROS in Fibrogenic Activity of Fibroblast Stem-like Cells
SWCNT-treated lung fibroblasts were subjected to FACS and isolated into SP and NSP with and
without antioxidant pretreatment. NAC and catalase pretreatment, in addition to inhibiting SP
(Figure 4A, 4B), also downregulated collagen I expression in SWCNT-treated SP fibroblasts
(Figure 4C, 4D and 4E, 4F). These results indicate the linkage between stem cell induction and
collagen production as well as their regulation by ROS.
Identification of Specific Antioxidant Enzymes in Fibroblast Stem-like Cells
Stem cells have been shown to possess special antioxidant defense mechanisms in order to ward
off elevated ROS levels and thus maintain their genomic identity.[27] To test the role of
antioxidant enzymes in FSC induction, human lung fibroblasts were exposed to SWCNTs, and
their SP and non-SP fractions were isolated by flow cytometry and subsequently analyzed for
their expression of antioxidant enzymes including catalase, superoxide dismutase and glutathione
peroxidase by Western blotting (Figure 5A). Interestingly, the expression of catalase, GPX1,
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SOD1 and SOD2 were downregulated in SP versus non-SP cells, suggesting that higher amounts
of antioxidant enzymes may be required to rescue the increased ROS production in CNT-induced
SP versus non-SP cells (Figure 5B, 5C). Furthermore, SP and non-SP cells isolated via flow
cytometry were analyzed for ROS generation by fluorometry using DCF-DA as fluorescent
probe for hydrogen peroxide. SP induced substantially higher DECF fluorescence intensities
compared to non-SP suggestive of peroxide anion formation (Figure 5D). The increased ROS
response in SP versus non-SPs could potentially explain the reduced antioxidant enzyme
expression in these stem-like cells.
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Discussion
ROS-dependent activation of transcription factors and signaling pathways has been
shown to regulate fibrosis.[19] CNTs have been shown to induce ROS generation in various cell
types [6, 15, 43, 44] mediating important cellular processes including inflammation, cell injury,
apoptosis, and activation of cellular signaling pathways implicated in the pathogenesis of lung
fibrosis. ROS have also been shown to be key regulators of stem cell renewal and
differentiation.[26-28] Previous studies have demonstrated the involvement of ROS in CNTinduced fibrogenic effects.[5, 15, 21, 22] However, whether ROS and stemness are associated
during CNT-induced fibrosis is not known. In this study, we demonstrated that ROS are essential
for inducing FSCs in human lung fibroblasts upon SWCNT exposure. Our findings are in good
agreement with previous studies indicating that stem cells maintain their genomic identity by
maintaining certain intracellular ROS levels.
Regulation of oxidative stress is critical for maintaining ‘‘stemness’’ and differentiation
of stem cells, as well as in progression of stem cell-associated disorders.[26, 27] In our model of
CNT-induced stem-like fibroblasts, ROS scavengers NAC and catalase successfully abrogated
the generation of FSCs from fibroblasts as evidenced by SP assay, implying that redox status of
the FSCs has a significant role in maintaining their identity (Figure 4A and 4B). Furthermore, the
SP fibroblasts generated from antioxidant pretreatment showed downregulation of collagen I
levels compared to SP without antioxidant pretreatment, revealing a novel role of ROS in CNTinduced stemness phenotype and the resulting fibrogenicity (Figure 4C and 4E). Thus, our
findings suggest that oxidative stress could potentially drive the CNT-induced stem cell activity;
moreover, the SP-driven fibrogenic effects are under the direct regulation of ROS.
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Next we investigated key antioxidant enzymes involved in the induction of FSCs and
maintenance of stemness during SWCNT-induced fibrogenesis. Interestingly, SWCNT-induced
SP fibroblasts down-regulated the expression of peroxide and superoxide-scavenging enzymes as
compared to non-SP fibroblasts which may likely occur in order to rescue the elevated ROS
response in SP over non-SP cells. In an event of increased oxidative stress, stem cells possess
antioxidant defense systems including ROS scavengers and antioxidants to rescue the decline in
their cellular properties and restore the functional properties.[45-47] Pluripotent stem cells
(PSCs) have been shown to possess limited ROS levels and superior antioxidant defense systems
to maintain their stemness via downregulation of antioxidant enzymes.[48] Moreover, a study on
human induced pluripotent stem cells (iPSCs) derived from Parkinson’s disease patients
demonstrated reduced efficiency of their antioxidant defense activity in disease-relevant
conditions.[49] These studies may possibly explain the reduced antioxidant enzyme expression
in SP versus non-SP fibroblasts observed in our study (Figure 5B, 5C) since we have
demonstrated the pathogenic role of SWCNT-derived FSCs in fibrogenesis.
The regulatory role of ROS in pulmonary fibrosis remains under intense investigations.
Since increased ROS production is tightly linked with pulmonary fibrosis [50], we investigated
the effect of SWCNTs on cellular ROS. SWCNTs induce substantial increase in cellular DCF
fluorescence, indicative of peroxide formation which was successfully abrogated by NAC and
catalase; but had minimal effect on DHE fluorescence indicative of superoxide formation.
One of the ways through which CNTs induce ROS includes the oxidant-generating
property of particles due to the presence of prooxidant functional groups on the reactive
surface.[7] Surface reactivity of CNTs is a key property enhancing their applicability.[51] During
their interaction with cells and tissues, surface chemistry plays a key role in determining the
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toxic responses. Surface charge present on acid-functionalized CNTs elicits inflammatory and
ROS response.[14, 52, 53] While comparing the ROS response between pristine and surfacemodified SWCNTs, pristine SWCNTs mounted a more robust ROS response compared to
nitrogen-containing and OH-functionalized SWCNTs. Variances within pristine and surfacemodified SWCNT-induced ROS response could be attributed to their differential cellular uptake
as the larger load of internalized CNTs may be responsible for the increased disruption of cell
membrane and intracellular organelles.[53, 54] Some authors have indicated an inverse
relationship between toxicity and purity of CNTs.[55] The SWCNTs used in this study were of
high purity (>99 % w/w) (Table 1). Clearly, apart from functionalization, many factors including
CNT uptake, internalization and phagocytosis influence the toxicity of CNTs.
Apart from surface modification, length also plays a key role in SWCNT-induced ROS
responses. As compared to control, both short and long SWCNTs induced a stronger oxidative
stress response (Figure 2B). Long SWCNTs elicited more robust ROS and fibrogenic responses
than short SWCNTs, indicating a length-dependent effect not associating with metal content
(Figure 3B, 3D). It is generally accepted that the presence of transition metal impurities such as
iron and nickel contributes to the oxidative stress and fibrotic effect of CNTs.[6, 56] In this
study, we used well characterized CNTs with known metal impurities to study the effects of fiber
length on ROS generation and fibrosis. Elemental analysis indicated low iron content for both
short (0.12 wt %) and long (0.13 wt %) SWCNTs compared to those reported in the previous
studies. Besides, no significant difference was observed in the elemental composition of the two
SWCNT samples used in this study (Table 2). Variances within short and long SWCNT-induced
ROS response could be attributed to their differential cellular uptake [54] or frustrated
phagocytosis.[57] Moreover, the difference observed between the short and long SWCNTs could
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be attributable to different cellular signaling pathways targeted by the two CNTs.[58] The higher
toxicity of long SWCNTs could be due to lipid peroxidation following the interaction between
cells and long SWCNTs.[59]
Interestingly, the antioxidant NAC significantly inhibited collagen production induced by
SWCNTs of varying lengths and surface modifications, indicating the involvement of ROS in
SWCNT-induced fibrogenic response (Figure 3). Moreover, ROS, particularly peroxides were
found to regulate FSCs and their collagen-producing activity (Figures 4, 5). These results suggest
the potential utility of ROS and FSC generation as rapid screening tools for fibrogenicity testing
of CNTs. In our study, SP fibroblasts derived after NAC pre-treatment downregulated collagen
expression compared to those without the NAC exposure, indicating that NAC possibly
promoted the differentiation of SP phenotype. Previous studies have shown that NAC facilitates
the differentiation of various cell types including neuronal cells, mouse embryonic stem cells and
ovary carcinoma cells among many others.[60-64] Our findings suggest a putative role played by
NAC in the self renewal of FSCs.
In addition to the direct ROS-inducing effect of CNTs, these nanomaterials can stimulate
lung inflammatory response leading to infiltration of inflammatory and immune cells such as
neutrophils and macrophages that can act as additional sources of ROS production.[65, 66] Thus,
inclusion of these cells in the fibroblast cell model system may increase the reliability and
predictability of the test model for CNT fibrogenicity assessment.
To summarize the findings from this study, we demonstrated that i) ROS, particularly
peroxides, are crucial for the induction of FSCs by SWCNTs, ii) the fibrogenic activity of these
cells is under the regulation of ROS, iii) SWCNT-mediated ROS response was dependent upon
their fiber length and surface modification, and iv) SWCNT-induced collagen expression was
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also length and functionalization dependent, and was regulated by ROS. Since FSCs possess
high fibrogenic activity and are the potential sources of fibroblasts and myofibroblasts, clarifying
their regulation is fundamental to the understanding of fibrosis mechanisms and the development
of effective treatment strategies.
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Figures

Figure I: Effect of SWCNT on ROS generation
A) NHLF cells were treated with SWCNT at the surface area dose of 0.15 μg/cm2 for 2 h, after which they
were incubated with dichlorodihydrofluorescein (DCF) and analyzed for fluorescence intensity. In some
cases, cells were pretreated with N-acetyl cysteine (10 mM) or catalase (1000 U/mL) for 1 h, and then
treated with SWCNT and analyzed for DCF fluorescence as described. B) Cells were pretreated with
MnTBAP (50 μM) for 1 h and then treated with SWCNT (0.15 μg/cm2) for 2 h, after which they were
incubated with dihydroethidium (DHE) and analyzed for fluorescence intensity. Plots are mean ± S.D.
(n = 4); * p < 0.05 as compared to untreated control; # p < 0.05 compared to SWCNT only.
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Figure II: Effect of SWCNT surface modification and length on ROS generation
After treatment with different SWCNTs at 0.06 μg/cm2, NHLF cells were incubated with
dichlorodihydrofluorescein (DCF) and fluorescence intensity was measured at 2 h post-treatment. In some
experiments, cells were pretreated for 1 h with N-acetyl cysteine (10 mM) or catalase (1000 U/mL) and
then treated with SWCNT and analyzed for DCF fluorescence as described. A) Effect of SWCNT surface
modification. B) Effect of SWCNT length. Plots are mean ± S.D. (n = 4); * p < 0.05 as compared to
control; # p < 0.05 vs. pristine-SW only; a, p < 0.05 compared to NF-SW only; b, p < 0.05 compared to
COOH-SW only; c, p < 0.05 compared to NC-SW only; d, p < 0.05 compared to OH-SW only. ** p <
0.05 compared to Short-SW only; e, p < 0.05 compared to Short-SW only; f, p < 0.05 compared to LongSW only.
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Figure III: Effect of ROS on SWCNT-induced fibrogenic response
NHLFs were pretreated for 1 h with NAC (10 mM) and then treated with SWCNTs for 48 h and analyzed
for collagen I expression by Western blotting. Blots were reprobed with β-actin antibody to confirm equal
loading of the samples. The immunoblot signals were quantified by Image J. A) Effect of SWCNT
functionalization. B) Effect of SWCNT length. C) Quantitative analysis of collagen I for SWCNTs of
different functionalization. D) Quantitative analysis of collagen I for SWCNTs of different lengths. Plots
are mean ± S.D. (n = 3); * p < 0.05 as compared to control; # p < 0.05 vs. pristine(NF)-SW only; a, p <
0.05 compared to NF-SW only; b, p < 0.05 compared to COOH-SW only; c, p < 0.05 compared to NCSW only; d, p < 0.05 compared to OH-SW only. ** p < 0.05 compared to Short-SW only; e, p < 0.05
compared to Short-SW only; f, p < 0.05 compared to Long-SW only.
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Figure IV: Role of ROS in SWCNT-induced fibroblast stem-like cells
A) SWCNT-treated NHLF cells isolated into SP and NSP with and without the inhibitor fumitremorgin C
(FTC) as indicated by the % population in the presence or absence of catalase (1000 U/ml), NAC (10
mM) or MnTBAP (50 μM). B) Redox-dependent FSC generation quantified by % SP population as
evidenced by treatment with various ROS scavengers. C) Type 1 collagen expression (relative to β-actin)
in SP cells with and without catalase treatment. D) Quantitative analysis of collagen I in SP cells E) Type
1 collagen expression (relative to β-actin) in SP cells with and without NAC treatment. F) Quantitative
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analysis of collagen I in SP cells The immunoblot signals were quantified by Image J. Plots are mean ±
S.D. (n = 3), * p < 0.05 as compared to control; # p < 0.05 compared to SWCNT-treated SP cells; ## p <
0.05 as compared to SP cells without catalase treatment; ** p<0,05 as compared to SP cells without NAC
treatment.
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Figure V: Antioxidant enzyme expression in SWCNT-induced fibroblast stem-like cells
A) SWCNT-treated NHLF cells isolated into SP and NSP with and without the inhibitor fumitremorgin C
(FTC). B) Differential antioxidant enzyme expression in SP and non-SP cells. Blots were reprobed with
β-actin antibody to confirm equal loading of the samples. C) The immunoblot signals were quantified by
Image

J.
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dichlorodihydrofluorescein (DCF) and fluorescence intensity was measured at 2 h post-treatment. Plots
are mean ± S.D. (n = 3), * p < 0.05 as compared to SP cells.
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CHAPTER 4: EFFECTS OF FIBER LENGTH AND SURFACE MODIFICATION ON
CARBON NANOTUBE-INDUCED FIBROBLAST STEM-LIKE CELLS AND LUNG
FIBROSIS
Abstract
Carbon nanotubes (CNTs) have increasing been used for a wide variety of applications, however,
given their extremely small size and light weight, these nanomaterials can be readily inhaled by
human lungs resulting in increased rates of pulmonary disorders, particularly fibrosis. Although
the fibrogenic potential of CNTs is well established, there is a lack of consensus regarding the
contribution of physicochemical attributes of CNTs on the underlying fibrotic outcome. We have
previously demonstrated the existence of fibroblast stem-like cells (FSCs) and their characteristic
role in single-walled (SW) CNT-induced fibrogenesis (Chapters 2, 3). However, it is not known
if these CNT characteristics including surface functionalization and fiber length influence the
ability of SWCNTs to induce FSCs. This study was designed to investigate whether SWCNT
functionalization and fiber length drive the stemness phenotype and the resulting fibrogenic
response. Our findings demonstrated that pristine SWCNT induced higher FSCs and collagen
expression compared to their chemically modified counterparts; however the difference was
moderate and not statistically significant. Whereas, long SWCNTs were significantly more
potent than short SWCNTs in terms of collagen production and stemness induction as evidenced
by elevated aldehyde dehydrogenase (ALDH) enzyme activity and side population (SP)
generation. Furthermore, our findings on the length-dependent in vitro fibrogenic response were
validated by the in vivo lung fibrosis outcome, thus supporting the predictive value of the FSC in
vitro model. Our results also demonstrated the key role of FSCs in SWCNT-induced collagen
expression, indicating the potential mechanisms of length-dependent CNT-induced lung fibrosis.
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Together, our study provides evidence that CNT-induced stem-like cell induction offers a new
rapid cell-based model for fibrogenicity testing of nanomaterials with the ability to predict
pulmonary fibrogenic response in vivo.
Keywords: SWCNT, functionalization, fiber length, fibroblast stem-like cell, fibrosis
Introduction
Because of their unique physicochemical properties such as high conductivity,
extraordinary tensile strength, and light weight, carbon nanotubes (CNTs) have emerged as one
of the most promising and best studied materials in nanotechnology [1, 2]. However, pristine
CNTs display low solubility and dispersibility in both organic and inorganic solutions, which
makes these materials difficult to handle and process during commercial use, thereby limiting
their widespread applications [3]. To overcome this issue, CNT surface can be functionalized by
introducing

hydrophilic

chemical

groups,

thus

imparting

higher

dispersibility

and

biocompatibility and conferring them new functions that cannot otherwise be acquired by
pristine CNTs [4]. As a result, they are widely used as additives [5], catalysts [6], sensors [7],
absorbents [8], intracellular carriers [9, 10], electrodes [11], and imaging agents [12]. However,
the rapid growth in functionalized CNT applications has necessitated an understanding of the
accompanying adverse health effects, which are currently being pursued by in vitro and in vivo
risk assessment studies [13]. For instance, CNT-elicited inflammation, ROS production, and
fibrosis are likely to be influenced by their physicochemical properties such as particle size,
dispersion status, fiber length, surface activity and presence of metal contaminants [2, 14].
Current literature reveals that functionalized CNTs exert considerable variations in their
biological effects, including cellular uptake [2, 15], clearance [16], genotoxicity [17],
inflammation, [18] and fibrogenicity [2] based on their surface charge. For instance, pristine
[100]

CNTs demonstrated an increased inflammatory and fibrotic responses compared to those of
carboxylated [19], pluronic-coated [20], taurine [21] and polystyrene-functionalized CNTs [22].
In a recent study, in comparison to pristine CNTs, strong cationic polyethylene imine (PEI)MWCNTs induced significant lung fibrosis, whereas carboxylation of the CNTs significantly
decreased the extent of fibrosis [2]. Similarly, another study showed that amine-modified CNTs
lead to increased pulmonary collagen deposition along with increased production of TGF-β1 and
IL-6 [23]. Given these contradictory outcomes and the paucity for studies outlining a clear effect
of functionalization on CNT-induced fibrosis, the need for systematic investigations of the
adverse effects of surface charge is imperative. Previous studies have suggested the role of
cellular uptake [2] and inflammasome activation [24, 25] for functionalization-dependent
toxicities, but the direct effect of SWCNT functionalization on fibrosis and its underlying
mechanisms need further investigations.
Besides surface reactivity, a number of studies have illustrated CNT length-dependent
effects on pleural inflammation and granuloma formation [26, 27], cytotoxicity [28], and
inflammasome activation [24]. Additionally, fiber length has been shown to regulate CNT
retention and clearance from the lungs [27, 29]. While recent studies have suggested incomplete
phagocytosis as a paradigm for CNT length-mediated toxic effects, the direct effect of SWCNT
length on fibrosis and the underlying mechanisms remain to be elucidated.
Recent findings from our lab indicate that fiber length [30] and surface functionalities can
influence CNT-induced fibrogenic response. We have previously demonstrated the existence of
fibroblast stem-like cells (FSCs) and their characteristic role in SWCNT-induced fibrogenesis
(Chapters 2 and 3). However, it is not known if these CNT characteristics, including surface
functionalization and fiber length, can influence the ability of CNTs to induce FSCs from lung
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fibroblasts. The main objective of this study was to investigate whether CNT functionalization
and fiber length influence stemness induction and the resulting fibrogenic response. To do this,
we employed SWCNTs of varying lengths and different functionalities, including pristine,
carboxyl (COOH), nitrogen-containing, and hydroxyl (OH). The latter part of this study involved
developing a model to determine whether the stemness phenotype of FSCs is predictive of the
fibrogenic response, which will in part also contribute towards the validation of Aim 1.

[102]

Experimental Section
SWCNT Preparation
SWCNTs were prepared by plasma purified chemical vapor deposition process and were
obtained from Cheap Tubes Inc. (Brattleboro, VT, USA). They were dispersed in culture
medium containing 5% serum by water-bath sonication. Before exposure to the cells, the
SWCNT dispersion was lightly sonicated (Sonic Vibra Cell Sonicator, Sonic & Material Inc.,
Newtown, CT, USA) with the power, frequency, and amplitude settings of 130 W, 20 kHz, and
60% respectively for 10 s.
Chemicals and Reagents
Antibody for collagen type I was obtained from Fitzgerald (Concord, MA, USA). β-actin
antibody and horseradish peroxidase (HRP)-conjugated secondary antibodies were obtained from
Santa Cruz Biotechnology (Santa Cruz, CA, USA). Hoechst 33342 was obtained from Sigma
Aldrich (St. Louis, MO). Aldefluor® kit was obtained from Stem Cell Technologies (Vancouver,
BC, Canada).
Energy Dispersive X-ray Spectroscopy (EDX-S) (Some experiments were performed in the
laboratory of Dr. Cerasela-Zoica Dinu)
EDX-S was used to perform elemental analysis of SWCNT samples. Data were collected on a
LEO 1530 VP scanning electron microscope equipped with an energy-dispersive X-ray analyzer
(Hitachi S-4700 Field Emission Scanning Electron Microscope, Hitachi High Technologies Co.,
Tokyo, Japan). A few drops of SWCNT dispersion in cell culture medium were placed on a
silicon wafer and allowed to air-dry. The silicon wafer was then mounted on an aluminum stub
for EDX-S analysis.
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Atomic Force Microscopy (AFM) (Some experiments were performed in the laboratory of Dr.
Cerasela-Zoica Dinu)
AFM was used to measure the length and diameter distribution of SWCNT samples using Digital
Instrument Nanoscope II (Model No. MFP-3D-AFM, Asylum Research, Goleta, CA, USA). A Si
tip (50-90 kHz AC240TS, Asylum Research, Goleta, CA, USA) was used to perform tapping
mode in air. SWCNT samples were deposited on mica surfaces (9.5 mm diameter, 0.15-0.21 mm
thickness, Electron Microscopy Sciences, Hatfield, PA, USA) and allowed to dry overnight
under vacuum. Scan angel was set as 0, scan rate was set as 0.5 Hz, and resolution was set as
512. Scan images of 20×20 or 10×10 μm areas were acquired. For each sample, at least 30
individual SWCNTs were counted and measured to obtain average length and diameter
distribution.
Cell Culture
Normal human lung fibroblasts (NHLFs) were obtained from Lonza (Walkersville, MD, USA).
The cells were maintained in Fibroblast Basal Medium (Lonza, CC-4126, Walkersville, MD,
USA) containing growth supplements. Lung diploid human fibroblasts WI-38 (#CCL-75) were
obtained from American Type Culture Collection (Manassas, VA, USA). The cells were
maintained in Minimum Essential Medium (Life Technologies, Grand Island, NY, USA). They
were cultured at 37 °C in 5% CO2 incubator and were passaged at preconfluent densities using a
medium containing 0.05% trypsin.
Cytotoxicity Assay
Cytotoxicity assay was carried out using WST-1 cell viability assay kit (Roche Molecular
Biochemicals, Indianapolis, IN, USA) as per the manufacturer’s instructions. Cells were plated
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in triplicate in 96-well plates at the density of 2.0×104 cells/well in CS-C medium. Following
overnight culture, the cells were incubated with the indicated concentrations of SWCNT for 48 h.
After incubation, WST-1 reagent was added and the cells were incubated for an additional 4 h.
The plates were then read at the wavelength of 420 nm using a microplate reader (Model 3550;
BioRad, Richmond, CA, USA).
Sircol® Collagen Assay
Soluble collagen content was determined by Sircol® assay (Biocolor Ltd., Belfast, UK),
according to the manufacturer’s protocol. Briefly, lung fibroblasts (1×105 cells/well) were
cultured in 6-well plates and treated with SWCNTs of different lengths at the indicated
concentrations for 24 and 48 h. Equal amounts of Sirius red reagent (Biocolor Ltd., Belfast, UK)
and cell culture supernatant (50 μL) were added together and mixed for 30 min. The collagendye complex was then precipitated by centrifugation at 13,000× g for 5 min, washed with
ethanol, and dissolved in 0.5 M NaOH. A 200 μL aliquot of the mixture was transferred to a 96well plate and analyzed for optical absorbance at 540 nm.
Western Blot Analysis
Collagen protein expression was determined by Western blotting. After specific treatments, cells
were incubated in lysis buffer containing 20 mM Tris-HCl (pH 7.5), 1% Triton X-100, 150 mM
sodium chloride, 10% glycerol, 1 mM sodium orthovanadate, 50 mM sodium fluoride, 100 mM
phenylmethylsulfonyl fluoride, and a commercial protease inhibitor mixture (Roche Molecular
Biochemicals, Indianapolis, IN, USA) at 4 °C for 20 min. Cell lysates were collected and protein
concentrations were determined using a bicinchoninic acid protein assay kit (Pierce
Biotechnology, Rockford, IL, USA). Equal amount of protein per sample (40 μg) was resolved
under denaturing conditions by 10% SDS-PAGE and transferred onto a nitrocellulose membrane.
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The membranes were blocked for 1 h in 5% nonfat dry milk in TBST (25 mM Tris-HCl, pH 7.4,
125 mM sodium chloride, 0.05% Tween 20) and incubated with appropriate primary antibodies
at 4 °C for 12 h. Membranes were washed thrice with TBST for 10 min and incubated with HRPlabeled isotype-specific secondary antibodies for 1 h at room temperature. The immune
complexes

were

then

detected

by

enhanced

chemiluminescence

detection

system

(Supersignal® West Pico, Pierce, Rockford, IL, USA). The bands were quantified via
densitometry using Image J. software, version 10.2 (GraphPad Software Inc., La Jolla, CA,
USA). Mean densitometry data from independent experiments were normalized to results in cells
from control experiments.
Isolation of FSCs using Flow Cytometry
Cell subsets enriched for stem cell activity were characterized by their ability to efflux the vital
dye Hoechst 33342 via multidrug-like transporter ABCG2. Following appropriate treatments, the
cells were harvested using 0.05% trypsin. Hoechst dye was added at a final concentration of 5
µg/mL to stain the lung fibroblasts. To ensure that SP is the accurate stem cell population, lung
fibroblasts should be co-stained Hoechst as well as with conjugated isotype-matched control
antibody which does not stain SP cells but stains a large fraction of the lung fibroblast pool.
Controls for flow cytometry included Hoechst-stained lung fibroblasts, unstained cells and cell
suspensions incubated with Hoechst 33342 and the dye uptake inhibitor FTC. Gates were set
according to the controls. The Hoechst dye was excited with a UV laser and its fluorescence was
measured with both 450/20 filter (Hoechst Blue) and 675 LP filter (Hoechst Red), sorting was
performed using FACS ARIA (BD Biosciences, San Jose, CA, USA).
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Aldehyde Dehydrogenase Assay
Human lung fibroblasts exposed to SWCNT for 24 h were analyzed using an Aldefluor ® assay
kit (Stem Cell Technologies, Vancouver, B.C., Canada). Dead cells, cell debris, doublets and
aggregates were excluded by forward and side scattering and pulse-width gating. Cells were
suspended in Aldefluor assay buffer containing ALDH substrate, BODIPY™-aminoacate (BAA)
(1 μM) for 30-60 min per 1×106 cells. After staining cells with the activated Aldefluor® reagent,
the single cell dissociation was maintained on ice during all subsequent procedures. In each
experiment, a sample of cells was stained under identical conditions with 1.5 mM of the specific
ALDH inhibitor diethylaminobenzaldehyde (DEAB) as a negative control. Flow cytometric
sorting was conducted using a FACS ARIA (BD Biosciences, San Jose, CA, USA). Aldefluor
fluorescence was excited at 488 nm, and fluorescence emission was detected using a standard
fluorescein isothiocyanate (FITC) 530/30-nm band-pass filter by a FACS Calibur™ machine
(BD Biosciences, San Jose, CA). High side scatter ALDH+ve and low ALDH−ve were selected.
SWCNT Animal Model (Some experiments were conducted at NIOSH, Morgantown)
Pathogen-free male C57BL/6J mice (Jackson Laboratories, Bar Harbor, ME, USA) weighing 2530 g were used in this study. Animals were housed in an “Association for Assessment and
Accreditation of Laboratory Animal Care” (AAALAC)-accredited, specific-pathogen-free,
environmentally controlled facility at National Institute for Occupational Safety and Health
(NIOSH). All experimental procedures were conducted in accordance with the protocol #11-LRM-018 approved by the Institutional Animal Care and Use Committee (IACUC). The animals
were treated with SWCNTs by pharyngeal aspiration. Briefly, animals were anesthetized by an
intraperitoneal injection of ketamine and xylazine (45 and 8 mg/kg) and placed on a board in the
supine position. The animal’s tongue was extended with padded forceps. A suspension of the test
[107]

material (40 μg/50 μL per mouse) was placed on the back of the tongue. A slight pull of the
tongue results in a reflex gasp and aspiration of the droplet. The tongue was held, and the animal
was monitored for a few breaths after aspiration. At 90 days post-exposure, mice were sacrificed
and lung tissues were isolated, homogenized, lysed and analyzed for collagen content by
Sircol® assay. For histopathology studies, paraffin-embedded lung sections were stained with
Sirius red and examined under a light microscope.
Statistical Analysis
The data represent mean ± S.D. from three or more independent experiments. ANOVA was
performed to determine statistical significance between treatment and control groups using
Graph Pad Prism 6.0 (GraphPad Software Inc., La Jolla, CA, USA) at a confidence level of * p <
0.05.
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Results
Physicochemical Characterization of Single-Walled Carbon Nanotubes
SWCNT samples of different lengths and surface functionalization were characterized using
atomic force microscopy (AFM) and energy dispersive X-ray spectroscopy (EDX-S) for size
measurements and elemental analysis, respectively. Table 1 provides information on the purity,
length and diameter characteristics for the SWCNT samples used in this study. The different
surface modified SWCNTs did not vary substantially in their diameter and lengths except in the
case of nitrogen-containing SWCNTs. Short and long SWCNTs differed slightly in their
diameter but very substantially in their length both in the solution and dry forms. For each
SWCNT type, particle lengths were comparable in the solution and dry forms, suggesting that
they were efficiently dispersed in the culture medium. Table 2 provides quantitative elemental
analysis for the SWCNT samples. Short SWCNTs were 92.82 wt % elemental carbon with 5.7
wt % oxygen, whereas long SWCNTs were 90.9 wt % carbon with 8 wt % oxygen. Both short
and long SWCNTs were similar in their elemental composition. Similarly, AFM was used to
characterize SWCNT samples of different functionalities.
FTIR Analysis for Identification of Various Functional Groups (Some experiments were
performed in the laboratory of Dr. Nianqiang Wu)
To confirm surface modification of SWCNTs via different functional groups, solid state FTIR
was performed to show the presence of the peaks that characterize each of these functional
groups on the nanotube surface (Figure 1). Pristine SWCNTs show the typical IR peaks, where i)
the 3420 cm-1 peak is assigned to the O-H stretching vibration, ii) 2850 cm-1 and 2970 cm-1 peaks
are ascribed to the asymmetric and symmetric vibrations of C-H, respectively, iii) whereas the
1643 cm-1 and 1590 cm-1 peaks are due to the benzene ring skeleton vibrations, and iv) 1170 cm-1
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and 1140 cm-1 peaks are from the C-O stretching vibration. Similar peaks were observed in other
SWCNT samples. However, the COOH-modified SWCNTs were observed to have a strong
stretching vibration peak of C=O around 1730 cm-1 which was not evident in other SWCNTs.
OH-modified SWCNTs reveal a strong stretching vibration peak of O-H around 3450 cm-1.
Moreover, the nitrogen-containing SWCNTs display the characteristic N-H wagging at 883 cm-1,
two characteristic peaks at 3760 cm-1 and 3650 cm-1 depicting asymmetric and symmetric N-H
stretch respectively, peaks at 1070 cm-1 and 1120 cm-1 suggesting C-N stretch vibrations of
aliphatic amines and a small peak observed at 1380 cm-1 which may imply of the C-N stretch
vibration of aromatic amines. The IR spectra suggest that our nitrogen-containing could
potentially be a mixture of aliphatic and aromatic amines.
Effect of SWCNTs on Cell Viability
This study was performed to optimize the experimental doses of SWCNTs that are relevant to in
vivo lung fibrosis. Lung fibroblasts were treated with different concentrations of SWCNTs for 48
h and analyzed for cell viability by WST-1 assay (Figure 2). The doses of 0.02-0.2 μg/cm2 were
used in this study since they are physiologically relevant and derived from pulmonary exposure
data in mice, i.e., 10-80 μg/mouse which corresponds to 0.02-0.16 μg/cm2 of mouse lung
alveolar surface area [19, 31, 32]. At the low-dose exposures of 0.02-0.06 µg/cm2, SWCNT
samples with various functional groups and lengths induced a reduction in cell viability; yet this
effect in cytotoxicity was relatively lower than that of 0.2 µg/cm2 which resulted in a significant
inhibition of cell proliferation (Figure 2A and 2B). The vehicle-treated control cells showed
minimal reduction in cell viability (Figure 2A and 1B). Both short and long SWCNTs induced a
dose-dependent decrease in cell viability of the cultured fibroblasts (Figure 2B). At equal dosing,
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long SWCNTs induced slightly more cellular toxicity than short SWCNTs, although the
difference was not statistically significant under the test conditions (Figure 2B).
Effect of SWCNTs on Type I Collagen Expression
Fibrosis is a fibroproliferative disorder characterized by excessive accumulation of ECM
proteins, especially collagens [33]. To determine the effect of SWCNT surface functionalization
and fiber length on fibrogenic response, human lung fibroblasts were exposed to SWCNTs for 48
h and type I collagen expression was determined by Western blotting, which was performed on
the basis of equal protein content, and the results were normalized by β-actin content (Figure 3).
Both pristine and modified SWCNTs substantially induced collagen expression compared to
untreated control (Figure 3A, 3C). Pristine SWCNTs were more potent in inducing collagen
expression compared to nitrogen-containing- and OH SWCNTs (Figure 3A and 3C). Moreover,
COOH-SWCNTs induced significantly higher collagen expression compared to nitrogencontaining-SWCNTs. Western blot data for SWCNT-induced collagen were validated via
Sircol® assay at 48 h post-SWCNT exposure. Analysis of total collagen content in SWCNTtreated cell supernatants by Sircol® collagen assay showed a similar functionalization-dependent
effect on soluble collagen content (Figure 3E). Figures 3B, 3D show that both long and short
SWCNTs induced a substantial increase in collagen production as determined by Western blot
assay. Analysis of soluble collagen content by Sircol® assay confirmed the result and indicated
the collagenic activity of SWCNTs (Figure 3F). Long SWCNTs were substantially more
fibrogenic than short SWCNTs based on the Western blot and Sircol® results.
Effect of Surface Functionalization on SWCNT-Induced FSC Generation
Recent evidence suggests that aldehyde dehydrogenase (ALDH) activity is a hallmark of adult
stem and progenitor cells isolated from bone marrow, brain, breast and possibly other tissues
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measurable by the Aldefluor assay [34]. ALDH activity plays a functional role in stem cell
survival, differentiation, expansion and oxidative stress response [35].

WI-38 human lung

fibroblasts were treated with pristine or surface modified SWCNTs at the dose of 0.15 μg/cm2 for
24 h, after which they were incubated with 0.3 mM activated Aldeflour dye in the presence or
absence of 1.5 mM ALDH inhibitor, DEAB (Figure 4). All SWCNT samples induced a
significantly increased ALDH activity compared to untreated control (Figure 4A, 4B). SWCNT
treatment generated ALDH +ve cells in a functionalization-dependent manner similar to their
fibrogenic response in vitro. Pristine SWCNTs induced substantial FSC generation and
significantly higher FSC level compared to nitrogen-containing- and OH-SWCNTs, however the
difference was not significant between pristine and COOH SWCNTs (Figure 4B).
Effect of Fiber Length on SWCNT-Induced FSC Generation
To determine the effect of fiber length on SWCNT-induced SP generation, human lung
fibroblasts were treated with SWCNTs of different lengths, and stem or stem-like cells were
isolated according to their SP phenotype using flow cytometry based cell sorting (Figure 5A,
5B). Both short and long SWCNTs generated substantially higher SP subpopulation compared to
vehicle-treated control. The percentage of long SWCNT-induced SP was significantly higher
compared to short SWCNT, thus indicating the role of fiber length in stemness induction (Figure
5A, 5B). Similarly, WI-38 human lung fibroblasts were treated with long and short SWCNTs at
the dose of 0.15 μg/cm2 for 24 h, after which they were incubated with 0.3 mM activated
Aldeflour dye in the presence or absence of 1.5 mM ALDH inhibitor, DEAB. Long SWCNTs
induced a substantially higher ALDH activity than short SWCNTs, confirming the effect of fiber
length on stemness phenotype (Figure 6A, B). However, both short and long SWCNTs induced a
significantly higher ALDH activity than the untreated control (Figure 6B).
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Stemness Phenotype is Predictive of the Fibrogenic Response in vitro and in vivo
To determine if our in vitro model of stemness induction is a suitable tool to assess the
fibrogenic response of SWCNTs. C57BL/6J mice were exposed to short and long SWCNTs via
pharyngeal aspiration and analyzed for lung fibrosis by Sircol ® collagen assay and
histopathology. Occupationally relevant dose of 40 μg/mouse and exposure time of 3 months
were used to ensure a robust fibrogenic response based on previous findings [36-38]. Lung
collagen content as determined by Sircol® assay was substantially upregulated in the SWCNTtreated mice compared to control mice (Figure 5B).
Long SWCNTs induced a higher fibrogenic response in mice than short SWCNTs, consistent
with the in vitro finding (Figure 7A, 7B). Histopathological analysis of lung tissue sections by
Sirius red staining confirmed the biochemical findings showing greater accumulation and
thickening of collagen fibers in the SWCNT-treated lung sections (Figure 7C). As compared to
alveolar tissue sections from vehicle (BSA)-treated lungs, both short and long SWCNTs induced
more collagen fibers which were condensed around SWCNT-deposited areas (observed
throughout the alveolar interstitial space) (Figure 7D).
Increased SP generation (Figure 5) and ALDH enzyme activity (Figure 6) correlated well with
the elevated length-dependent fibrogenic response of SWCNTs in vivo, thereby validating our
fibroblast stem cell model of CNT-induced fibrogenesis. The findings from this study also
indicate the role of fiber length as a key physicochemical determinant of CNT-induced stemness
and lung fibrosis, whereby the stemness model was predictive of the in vivo fibrogenic response.
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Discussion
Lung fibrosis induced by SWCNTs has been well documented [19, 31, 32, 39-43], but the
effect of specific SWCNT properties on lung fibrosis remains controversial and largely
undefined [44]. Revealing the physicochemical properties influencing CNT fibrogenicity is
essential due to the promise surrounding CNT exploitation. For instance, functionalized CNTs
are generally considered more biocompatible than pristine CNTs because of their improved
hydrophilicity and dispersion in biological media making them easier to use for a variety of
commercial applications [5]. However, the potential adverse effects of functionalized CNTs have
not been well characterized or systematically explored. Several potential mechanisms of CNTinduced fibrosis have been suggested, including epithelial mesenchymal transition [40], profibrogenic mediators [41], and oxidative stress [42]. The direct effect of functionalization on
CNT-generated fibrogenicity remains inconclusive owing to the contradictory reports in the
literature. Besides surface reactivity, length has been suggested to play a critical role in the
biological reactivity of CNTs. Although a few studies have reported the length effect of CNTs on
lung toxicity and while recent studies have suggested incomplete phagocytosis as a paradigm for
CNT length-mediated toxicities, the effect of fiber length on SWCNT-induced lung fibrosis and
its underlying mechanism have not been reported.
Based on the results from Chapters 2 and 3, we demonstrated a functional role of stemlike fibroblasts in CNT-induced fibrogenic response. Furthermore, the isolated stem-like
fibroblasts were potential key source for collagen and α-SMA production, thus playing a crucial
role in fibrogenesis. The present study was designed to evaluate whether surface
functionalization and fiber length influenced FSC generation during CNT-induced fibrosis and to
develop an in vitro model based on the FSC generation to predict the fibrogenic response in vivo.
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Our results showed that 1) pristine SWCNTs induced a higher level of FSCs compared to their
chemically modified counterparts; 2) long SWCNTs induced substantially higher stem cell
activity compared to short SWCNTs; and 3) the ability of SWCNTs with different lengths to
induce FSCs mimicked their fibrogenic activity in vivo, suggesting that CNT-induced stemness
phenotype is predictive of their fibrogenicity in vivo.
Identifying the cells that are responsible for repairing the injured tissue and are the source
of ECM production is fundamental to the understanding of fibrosis mechanisms [45, 46]. Recent
studies have demonstrated the pathogenic role of stem-like cells in lung fibrosis; however, the
concept of stemness in the light of nanomaterial-induced fibrosis remains to be explored [47, 48].
Furthermore, the existence and role of fibroblast-derived stem cells have not been described. As
mentioned before, ALDH activity has been shown to act as a functional marker for
stem/progenitor cells [35]. Our model aimed at critically analyzing the ability of SWCNTs of
various lengths and surface modifications to induce high levels of ALDH activity. Pristine
SWCNTs induced a substantially higher ALDH activity compared to their modified forms.
Additionally, this effect of CNT functionalization on stem cell induction correlated well with the
fibrogenic response in vitro. Likewise, compared to short SWCNTs, long SWCNTs exhibited a
stronger stem cell-inducing effect, as evidenced by their increased SP generation and ALDH
activity. The increased stem cell activity was corroborated by the fibrogenic response of long
SWCNTs both in vitro and in vivo, thus supporting the predictive value of our stem cell model
for the detection of fibrogenic effect of nanomaterials.
We reported the effect of CNT fiber length on lung fibrosis in vivo as determined by
histological analysis of Sirius Red stained lung sections from control and three-month short and
long SWCNT aspiration. Additionally, long SWCNTs were potent inducer of collagen
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expression than short SWCNTs in vitro as determined by Western blot and Sircol® assays.
Similarly, pristine SWCNTs mounted a strong fibrogenic response compared to nitrogencontaining and OH SWCNTs in vitro. Our surface modification-dependent fibrogenic results are
in agreement with previous studies where functionalized CNT demonstrate reduced pulmonary
inflammation and fibrosis [20-22, 49]. Whereas recent reports showed that functionalized tubes
such as NH2, amide-CNTs and PEI-CNTs, are capable of inducing robust fibrogenic responses
compared to their pristine counterparts [2, 23, 50]. Although surface charge is a potential factor
responsible for the variable in vivo fibrogenic responses, these inconsistencies response
outcomes could be attributed to the complex and multivariate differences in the tube structure
derived from different suppliers and method of functionalization [2].
The collagen-inducing effect of SWCNTs (Figure 3A, 3B) was not due to their
proliferative activity since fibroblast cell growth was not increased by the SWCNT treatment as
indicated by WST-1 assay (Figure 2A, 2B). Moreover, all collagen expression data presented in
this study were normalized against β-actin or cellular content as described in the Experimental
section. We observed that the fibrogenic response elicited via SWCNTs of various functionalities
and lengths corresponded in good agreement with their ability to induce FSCs (Figure 3A, 3B).
Since collagen deposition is a hallmark of lung fibrosis, cellular collagen content could be used
as a functional assay for nanoparticle fibrogenicity in vitro.
An additional key finding from this study was the correlation between the in vitro and in
vivo SWCNT length-dependent responses, indicating the potential usefulness of the in
vitro stemness induction model as a predictive screening tool for fibrogenicity testing of
nanomaterials. The three-month aspiration study in mice demonstrated a length-dependent
fibrogenicity in vivo as evidenced from the histopathological and biochemical studies showing
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greater fibrogenicity of long over short SWCNTs (Figure 7C, 7D). Furthermore, long SWCNTs
induced significantly higher FSCs compared to short SWCNTs, supporting the fiber length
paradigm [51] in stemness induction (Figures 5A, 5B and 6A, 6B). These findings validate the
reliability of our in vitro stemness phenotype model to be used as an alternative assay to predict
the fibrogenicity of CNTs and other nanomaterials for their safer design and risk assessment.
The described in vitro model is based on the use of lung fibroblasts which are the main
cellular source of collagen production whose accumulation epitomizes lung fibrosis [33].
However, because of the lack of inflammatory and epithelial cells in the test system which are
involved in the fibrogenic process, future studies incorporating these cells to better mimic the in
vivo conditions are warranted. Currently, there is a need for simple and rapid in vitro models for
fibrogenicity testing of nanomaterials since traditional assays which rely on the use of animal
models are time consuming, laborious, and costly. They are not suitable for screening a large
number of nanomaterials currently being used or developed. Developing a reliable and predictive
screening model apriori is beneficial for understanding the influence of physicochemical
parameters on pulmonary fibrosis before performing targeted animal experiments. Our study
presents a predictive toxicological paradigm for comparing multiple parameters of CNTs in a
single round of experimentation via assessment of mechanistic endpoint of stemness induction
and collagen expression, critical in the pathogenesis of fibrosis.
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Figures

Dispersed form

Table I: Physicochemical characterization of Single walled carbon nanotubes (SWCNTs) of
different surface modifications and lengths
Note: The table describes the purity, diameter and length distribution measured via AFM.

Table II: Elemental analysis for short and long SWCNTs
Elemental analysis of SWCNTs of different lengths measured via EDX-S.
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Figure I: FTIR spectra for pristine and surface modified Single walled carbon nanotubes
(SWCNTs)
FTIR spectra for pristine and modified SWCNTs. Strong stretching vibration peak of C=O
around 1730 cm-1 as well as O-H stretching vibrations at 3430 cm-1 are in the COOH SWCNTs
respectively. Characteristic N-H wagging at 883 cm-1 and a small peak observed at 1380 cm-1
resulting from the C-N stretch vibration found in nitrogen-containing SWCNTs.
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Figure II: Effect of SWCNTs on cell viability
Subconfluent cultures of normal human lung fibroblasts were exposed to SWCNTs of various
lengths and surface modification for 48 h within the concentration range of 0.02-0.2 μg/cm2. Cell
viability was determined by WST-1 assay and compared to untreated control. A) Effect of fiber
length and B) surface modification on cell viability. Values are means ± SD (n = 3); * p < 0.05
vs. untreated control.
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Figure III: Effect of SWCNTs on type I collagen expression

A) Western blots showing functionalization-dependent effect of SWCNTs on collagen I
production. B) Western blots showing fiber length-dependent effect of SWCNTs on collagen I
production. Subconfluent cultures of human lung fibroblasts were treated with SWCNTs with
various functionalities and lengths for 48 h and analyzed for collagen I expression by Western
blotting. Blots were reprobed with β-actin antibody to confirm equal loading of the samples. The
immunoblot signals were quantified by Image J. C) and D) Relative protein quantification via
Image J. Values are means ± SD (n = 3); * p < 0.05 vs. untreated control; # p < 0.05 vs. pristineSWCNT; δ p<0.05 vs. short-SWCNT.
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Figure IV: Effect of SWCNT surface modification on FSC generation via Aldefluor® assay
Human lung fibroblasts were treated with modified and pristine SWCNTs (0.15 μg/cm2) for 24 h
and stained with Aldeflour® dye in the presence or absence of 1.5 mM ALDH inhibitor,
diethylaminobenzaldehyde (DEAB). A) Cells with increased ALDH activity (ALDH

Hi)

were

characterized and isolated by FACS. B) Quantitative analysis of % ALDH activity in SWCNTtreated human lung fibroblasts compared to control. Data are means ± SD (n = 3). *p < 0.05
versus control cells.
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Figure V: Effect of SWCNT length on FSC induction determined by side population (SP)
assay
A) Short and long SWCNT-treated human lung fibroblasts isolated into SP and NSP with or
without the inhibitor fumitremorgin C (FTC) as indicated by % population. B) % SP population
in short and long SWCNT-treated lung fibroblasts as compared to vehicle-treated control. Data
are means ± SD (n =3). *p < 0.05 vs. control cells. # p < 0.05 vs. short-SWCNT.
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Figure VI: Effect of SWCNT length on FSC generation via Aldeflour® assay
WI-38 human lung fibroblasts were treated with SWCNTs of different lengths (0.15 μg/cm2) for
24 h and stained with the Aldeflour dye in the presence or absence of 1.5 mM ALDH inhibitor,
diethylaminobenzaldehyde (DEAB) for ALDH activity analysis. A) Cells with increased ALDH
activity (ALDH

Hi)

were characterized and isolated by FACS. B) Quantitative analysis of %

ALDH activity in SWCNT-treated lung fibroblasts compared to control. Data are means ± SD (n
= 3). *p < 0.05 vs. control cells. # p < 0.05 vs. short-SWCNT.
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Figure VII: Effect of SWCNT length on fibrogenic response in vitro and in vivo
A) Western blots showing length-dependent effect of SWCNTs on collagen I production.
Subconfluent cultures of human lung fibroblasts were treated with SWCNTs of different lengths
for 48 h and analyzed for collagen I expression by Western blotting. Blots were reprobed with βactin antibody to confirm equal loading of the samples. B) Quantitative analysis of collagen I
expression. C) Mice were exposed to 50 μL of dispersed SWCNT (40 μg/mouse) via pharyngeal
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aspiration for 90 days, after which the animals were sacrificed and the lungs were isolated, lysed
and analyzed for histopathology after Sirius red staining. Scale bar = 20 μm; Arrows denote the
thickening of collagen fibers around the CNTs. D) soluble collagen content by Sircol® assay.
Values are means ± SD, (n = 5 mice/group); * p < 0.05 vs. BSA/dipalmitoyl phosphatidylcholine
(DPPC)-treated control; # p < 0.05 vs. short-SWCNT.
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CHAPTER 5
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CHAPTER 5: EXECUTIVE SUMMARY
Introduction
Given their remarkable properties, carbon nanotubes (CNTs) have made their way
through various industrial and medicinal applications. The overall production of CNTs and their
products is expected to grow rapidly in the next decade, thus requiring an additional recruitment
of workers [1-3]. However, their unique applications and desirable properties are fraught with
concerns regarding occupational exposure. The concern about worker exposure to CNTs arises
from the results of recent animal studies. Short-term and sub-chronic exposure studies in rodents
have shown consistent adverse health effects such as pulmonary inflammation, granulomas,
fibrosis, and mesothelioma [4-8]. Furthermore, physicochemical properties of CNTs such as
aspect ratio, dispersion, and functionalization can significantly affect their pulmonary toxicity [911].
CNTs can evade phagocytosis, cross cell membranes and the blood-brain barrier and
translocate to other sites of the body causing systemic side effects [12]. Once inhaled, CNTs can
cross the alveolar interstitial barrier and typically end up in the interstitial compartment of the
lung. Subsequent in vitro studies show that CNTs interact with interstitial fibroblast cells to
induce excessive extracellular matrix (ECM) accumulation. The clearance rate of these
nanomaterials is extremely low, owing to their non-biodegradable nature resulting in biopersistence and tissue burden, leading to a higher probability of adverse health effects [2, 4].
Considerable investigations in the literature demonstrate the fibrogenic effect of CNTs; however,
the underlying mechanisms remain poorly understood.
Pulmonary fibrosis is a progressive and lethal lung disease characterized by excessive
proliferation of fibroblasts and deposition of ECM [13]. Identifying the cells responsible for the
[133]

enhanced ECM and collagen production is crucial for understanding fibrosis mechanisms.
Growing research indicates the presence of putative stem cells in the pathogenesis of pulmonary
fibrosis [14]. For instance, a recent study has indicated the stem cell induction at the early onset
of lung fibrosis in a mouse model of bleomycin-induced fibrosis [15]. However, the role of stem
cells in nanomaterial-induced pulmonary fibrosis has not been explored.
At present, human data regarding fibrogenicity assessment of CNTs is lacking and
information on in vivo toxicity is limited. Murine models appear to be a gold standard for the
assessment of lung fibrosis [16]. However, the rapidly expanding number of engineered
nanomaterials makes it impossible to test them all in animals due to time constraints and
prohibitive cost. Currently, there is a dire need for efficient and reliable in vitro models which
can facilitate the rapid high-throughput assessment of nanomaterial fibrogenicity and disease
mechanisms [17].
In order to elucidate the mechanism of CNT-induced fibrosis, we hypothesize that CNT
exposure to fibroblasts induces FSCs which are crucial for the fibroblast to myofibroblast
transformation and the development of fibrosis. The specific aims of this study are designed, first
of all, to establish the evidence of fibroblast stem-like cells (FSCs) upon SWCNT exposure,
characterize their role in the fibrogenesis, and lastly to evaluate whether oxidative stress and
physicochemical parameters of CNTs influence the resulting stemness phenotype. Oxidative
stress was specifically studied since it is the most commonly reported SWCNT toxicity endpoint
and has been demonstrated to be a key player in stem cell fate and function.
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Specific Aim 1: Characterize the role of fibroblast stem-like cells in CNT-induced lung
fibrosis
Background

Currently the paradigm of stem cells is being evaluated in dysfunctional lung remodeling.
Evolving research has demonstrated the pathogenic role of these stem/progenitor cells during the
early onset of lung fibrosis in vivo [14, 15]. Stem cells triggered by environmental cues
differentiate into myofibroblasts and contribute to disease progression. Understanding the
molecular/cellular basis of these stem-like cells during lung fibrosis is of critical importance.
Previous research findings and studies from our laboratory have shown the fibrogenic potential
of CNTs [18-20]. However, the concept of stemness in the light of nanomaterial-induced fibrosis
remains to be explored. Therefore, we proposed that fibroblasts can be a source of stem-like cells
upon exposure to CNTs. The goal of this aim was to document the evidence of FSCs and their
potential role in CNT-induced fibrogenic effects both in vivo and in vitro settings.
Rationale
Previous findings from our laboratory revealed the expression of universal stem cell markers
ALDH1A1 and ABCG2 in human lung fibrotic tissues [21] as well as CNT-induced FSCs thus
providing evidence for the clinical relevance of stem cells in fibrosis. These data provide
preliminary supporting evidence for the role of stem cells in human lung fibrosis.
Results
SWCNTs induced the side population phenotype (indicative of the fibroblast stem-like cell
phenotype) of primary lung fibroblasts. CNT-induced SP cells (FSCs) expressed a high level of
both collagen I and α-SMA compared to non-SP indicating that the stem-like fibroblasts are a
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potential key source of collagen production and may play a crucial role in fibrogenesis. The
isolated FSCs displayed an elevated expression of fibrogenic and stem cell markers indicating
the reliability of the stem cell isolation method via FACS as well as supporting their critical role
in SWCNT-induced fibrogenesis. The study also developed and put forth an in vitro model of
SWCNT-induced fibrotic nodule formation that correlates the development of stemness
phenotype and onset of fibrosis.
Specific Aim 2: Determine whether reactive oxygen species (ROS) production is involved in
CNT-induced stemness.
Background
Accumulating evidence suggests the redox potential of CNTs [22]. Nanoparticle exposure results
in ROS-dependent activation of several transcription factors and signaling pathways involved in
the regulation of inflammation and fibrosis [23]. ROS are known to regulate several cellular
responses such as SWCNT-induced collagen production, fibroblast to myofibroblast activation,
and angiogenesis, all implicated in the pathogenesis of fibrosis [18, 24]. ROS signaling has been
shown to drive the metabolic state of stem cells thereby governing their stemness and
differentiation as well as implicated in the progression of stem cell-associated diseases [25, 26].
However, it is unknown whether the oxidative stress induced by SWCNTs is essential for the
development of stem phenotype of FSCs. This study was undertaken to evaluate whether ROS
are critical for the development of stem phenotype during CNT-induced fibrogenesis.
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Rationale
Previous findings from our group indicate that ROS generation plays a key role in CNT-induced
fibrogenesis [18, 19]. Oxidative stress has also been shown to affect stem cell function and
behavior [25].
Results
SWCNT-induced FSC generation was under the regulation of oxidative stress as indicated by i)
antioxidants abrogated the effect of SWCNTs on FSC (SP) generation, ii) role of peroxides in
SWCNT-induced FSC generation, iii) SWCNT-induced FSCs overexpressed collagen I, which
was shown to be ROS-dependent, and iv) CNT length and surface modification dependent ROS
responses. Overall, our findings indicate that ROS are essential for imparting stemness to
SWCNT-treated fibroblasts.
Specific Aim 3: Study the effects of fiber length and surface modification on carbon
nanotube-induced fibroblast stem-like cells and lung fibrosis
Background
The pathologic effects of CNTs such as inflammation, ROS production, and fibrosis are likely to
be influenced by their physicochemical properties such as particle size, dispersion and surface
activity with respect to their cellular uptake, internalization, phagocytosis and clearance from the
body [27, 28]. Studies from our laboratory as well as other groups have demonstrated the
differential fibrogenic response owing to different sizes, dispersion status, and chemical
functionalization of nanomaterials [9-11, 19]. SWCNT exposure causes FSC generation in
human lung fibroblasts as demonstrated in chapter 1. However, it is not known if these CNT
characteristics are capable of driving the stemness phenotype in SWCNT-treated lung
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fibroblasts. Thus, the major objective of this aim was to understand an association between
SWCNT surface modification and fiber length and stemness development. This study also aimed
to develop a model that determines whether stemness phenotype is predictive of the fibrogenic
response in vivo.
Results
Long SWCNTs induced higher FSCs compared to short SWCNTs as evidenced by side
population (SP) and (aldehyde dehydrogenase) ALDH assays, thus indicating a length-dependent
effect on stemness phenotype. Pristine SWCNTs induced higher FSCs compared to modified
SWCNTs; however the effect was not statistically different. Long SWCNTs induced greater
fibrogenic response in vivo compared to short SWCNTs, supporting the potential utility of our in
vitro FSC model to predict the fibrogenicity of CNTs.
Clinical & Translational Relevance
The work presented in this study is innovative because it introduces the concept of fibroblast
stem-like cells as a potential key player in the pathogenesis of pulmonary fibrosis. These cells,
which possess stem property and high fibrogenic activity, were induced by CNTs and could
serve as a potential key source of ECM production whose accumulation characterizes fibrosis.
This work has a broad impact on stem cell development and is applicable to other nanomaterials
and fibrogenic agents. It also provides new insight into the mechanisms of fibrosis which may
help to identify novel biomarkers and drug targets for early diagnosis and treatment of the
disease. Furthermore, the in vitro FSC model developed in this study may be utilized as a rapid
screening tool for fibrogenicity testing of nanomaterials and anti-fibrotic agents.
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